<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2003-10-31" modified="2020-10-07" version="199">
<accession>Q96EB6</accession>
<accession>Q2XNF6</accession>
<accession>Q5JVQ0</accession>
<accession>Q9GZR9</accession>
<accession>Q9Y6F0</accession>
<name>SIR1_HUMAN</name>
<protein>
<recommendedName>
<fullName evidence="107">NAD-dependent protein deacetylase sirtuin-1</fullName>
<shortName>hSIRT1</shortName>
<ecNumber evidence="22">2.3.1.286</ecNumber>
</recommendedName>
<alternativeName>
<fullName>NAD-dependent protein deacylase sirtuin-1</fullName>
<ecNumber evidence="18">2.3.1.-</ecNumber>
</alternativeName>
<alternativeName>
<fullName>Regulatory protein SIR2 homolog 1</fullName>
</alternativeName>
<alternativeName>
<fullName>SIR2-like protein 1</fullName>
<shortName>hSIR2</shortName>
</alternativeName>
<component>
<recommendedName>
<fullName>SirtT1 75 kDa fragment</fullName>
<shortName>75SirT1</shortName>
</recommendedName>
</component>
</protein>
<gene>
<name type="primary" evidence="112">SIRT1</name>
<name type="synonym">SIR2L1</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1999" name="Biochem. Biophys. Res. Commun." volume="260" first="273" last="279">
<title>Characterization of five human cDNAs with homology to the yeast SIR2 gene: Sir2-like proteins (sirtuins) metabolize NAD and may have protein ADP-ribosyltransferase activity.</title>
<authorList>
<person name="Frye R.A."/>
</authorList>
<dbReference type="PubMed" id="10381378"/>
<dbReference type="DOI" id="10.1006/bbrc.1999.0897"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>TISSUE SPECIFICITY</scope>
<source>
<tissue>Testis</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="2003" name="Biochem. Biophys. Res. Commun." volume="301" first="250" last="257">
<title>Human Sir2-related protein SIRT1 associates with the bHLH repressors HES1 and HEY2 and is involved in HES1- and HEY2-mediated transcriptional repression.</title>
<authorList>
<person name="Takata T."/>
<person name="Ishikawa F."/>
</authorList>
<dbReference type="PubMed" id="12535671"/>
<dbReference type="DOI" id="10.1016/s0006-291x(02)03020-6"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH HES1 AND HEY2</scope>
<scope>MUTAGENESIS OF HIS-363</scope>
<scope>ACTIVE SITE</scope>
</reference>
<reference key="3">
<citation type="submission" date="2005-11" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="NIEHS SNPs program"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANT GLU-3</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Nature" volume="429" first="375" last="381">
<title>The DNA sequence and comparative analysis of human chromosome 10.</title>
<authorList>
<person name="Deloukas P."/>
<person name="Earthrowl M.E."/>
<person name="Grafham D.V."/>
<person name="Rubenfield M."/>
<person name="French L."/>
<person name="Steward C.A."/>
<person name="Sims S.K."/>
<person name="Jones M.C."/>
<person name="Searle S."/>
<person name="Scott C."/>
<person name="Howe K."/>
<person name="Hunt S.E."/>
<person name="Andrews T.D."/>
<person name="Gilbert J.G.R."/>
<person name="Swarbreck D."/>
<person name="Ashurst J.L."/>
<person name="Taylor A."/>
<person name="Battles J."/>
<person name="Bird C.P."/>
<person name="Ainscough R."/>
<person name="Almeida J.P."/>
<person name="Ashwell R.I.S."/>
<person name="Ambrose K.D."/>
<person name="Babbage A.K."/>
<person name="Bagguley C.L."/>
<person name="Bailey J."/>
<person name="Banerjee R."/>
<person name="Bates K."/>
<person name="Beasley H."/>
<person name="Bray-Allen S."/>
<person name="Brown A.J."/>
<person name="Brown J.Y."/>
<person name="Burford D.C."/>
<person name="Burrill W."/>
<person name="Burton J."/>
<person name="Cahill P."/>
<person name="Camire D."/>
<person name="Carter N.P."/>
<person name="Chapman J.C."/>
<person name="Clark S.Y."/>
<person name="Clarke G."/>
<person name="Clee C.M."/>
<person name="Clegg S."/>
<person name="Corby N."/>
<person name="Coulson A."/>
<person name="Dhami P."/>
<person name="Dutta I."/>
<person name="Dunn M."/>
<person name="Faulkner L."/>
<person name="Frankish A."/>
<person name="Frankland J.A."/>
<person name="Garner P."/>
<person name="Garnett J."/>
<person name="Gribble S."/>
<person name="Griffiths C."/>
<person name="Grocock R."/>
<person name="Gustafson E."/>
<person name="Hammond S."/>
<person name="Harley J.L."/>
<person name="Hart E."/>
<person name="Heath P.D."/>
<person name="Ho T.P."/>
<person name="Hopkins B."/>
<person name="Horne J."/>
<person name="Howden P.J."/>
<person name="Huckle E."/>
<person name="Hynds C."/>
<person name="Johnson C."/>
<person name="Johnson D."/>
<person name="Kana A."/>
<person name="Kay M."/>
<person name="Kimberley A.M."/>
<person name="Kershaw J.K."/>
<person name="Kokkinaki M."/>
<person name="Laird G.K."/>
<person name="Lawlor S."/>
<person name="Lee H.M."/>
<person name="Leongamornlert D.A."/>
<person name="Laird G."/>
<person name="Lloyd C."/>
<person name="Lloyd D.M."/>
<person name="Loveland J."/>
<person name="Lovell J."/>
<person name="McLaren S."/>
<person name="McLay K.E."/>
<person name="McMurray A."/>
<person name="Mashreghi-Mohammadi M."/>
<person name="Matthews L."/>
<person name="Milne S."/>
<person name="Nickerson T."/>
<person name="Nguyen M."/>
<person name="Overton-Larty E."/>
<person name="Palmer S.A."/>
<person name="Pearce A.V."/>
<person name="Peck A.I."/>
<person name="Pelan S."/>
<person name="Phillimore B."/>
<person name="Porter K."/>
<person name="Rice C.M."/>
<person name="Rogosin A."/>
<person name="Ross M.T."/>
<person name="Sarafidou T."/>
<person name="Sehra H.K."/>
<person name="Shownkeen R."/>
<person name="Skuce C.D."/>
<person name="Smith M."/>
<person name="Standring L."/>
<person name="Sycamore N."/>
<person name="Tester J."/>
<person name="Thorpe A."/>
<person name="Torcasso W."/>
<person name="Tracey A."/>
<person name="Tromans A."/>
<person name="Tsolas J."/>
<person name="Wall M."/>
<person name="Walsh J."/>
<person name="Wang H."/>
<person name="Weinstock K."/>
<person name="West A.P."/>
<person name="Willey D.L."/>
<person name="Whitehead S.L."/>
<person name="Wilming L."/>
<person name="Wray P.W."/>
<person name="Young L."/>
<person name="Chen Y."/>
<person name="Lovering R.C."/>
<person name="Moschonas N.K."/>
<person name="Siebert R."/>
<person name="Fechtel K."/>
<person name="Bentley D."/>
<person name="Durbin R.M."/>
<person name="Hubbard T."/>
<person name="Doucette-Stamm L."/>
<person name="Beck S."/>
<person name="Smith D.R."/>
<person name="Rogers J."/>
</authorList>
<dbReference type="PubMed" id="15164054"/>
<dbReference type="DOI" id="10.1038/nature02462"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 124-747</scope>
<source>
<tissue>Prostate</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="2001" name="Cell" volume="107" first="149" last="159">
<title>hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase.</title>
<authorList>
<person name="Vaziri H."/>
<person name="Dessain S.K."/>
<person name="Ng Eaton E."/>
<person name="Imai S."/>
<person name="Frye R.A."/>
<person name="Pandita T.K."/>
<person name="Guarente L."/>
<person name="Weinberg R.A."/>
</authorList>
<dbReference type="PubMed" id="11672523"/>
<dbReference type="DOI" id="10.1016/s0092-8674(01)00527-x"/>
</citation>
<scope>FUNCTION IN DEACETYLATION OF TP53</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF HIS-363</scope>
<scope>ACTIVE SITE</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2002" name="EMBO J." volume="21" first="2383" last="2396">
<title>Human SIR2 deacetylates p53 and antagonizes PML/p53-induced cellular senescence.</title>
<authorList>
<person name="Langley E."/>
<person name="Pearson M."/>
<person name="Faretta M."/>
<person name="Bauer U.-M."/>
<person name="Frye R.A."/>
<person name="Minucci S."/>
<person name="Pelicci P.G."/>
<person name="Kouzarides T."/>
</authorList>
<dbReference type="PubMed" id="12006491"/>
<dbReference type="DOI" id="10.1093/emboj/21.10.2383"/>
</citation>
<scope>FUNCTION</scope>
<scope>ENZYME ACTIVITY</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH PML</scope>
<scope>MUTAGENESIS OF HIS-363</scope>
<scope>ACTIVE SITE</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="45099" last="45107">
<title>Inhibition of silencing and accelerated aging by nicotinamide, a putative negative regulator of yeast sir2 and human SIRT1.</title>
<authorList>
<person name="Bitterman K.J."/>
<person name="Anderson R.M."/>
<person name="Cohen H.Y."/>
<person name="Latorre-Esteves M."/>
<person name="Sinclair D.A."/>
</authorList>
<dbReference type="PubMed" id="12297502"/>
<dbReference type="DOI" id="10.1074/jbc.m205670200"/>
</citation>
<scope>ACTIVITY REGULATION</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2003" name="Nature" volume="425" first="191" last="196">
<title>Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan.</title>
<authorList>
<person name="Howitz K.T."/>
<person name="Bitterman K.J."/>
<person name="Cohen H.Y."/>
<person name="Lamming D.W."/>
<person name="Lavu S."/>
<person name="Wood J.G."/>
<person name="Zipkin R.E."/>
<person name="Chung P."/>
<person name="Kisielewski A."/>
<person name="Zhang L.-L."/>
<person name="Scherer B."/>
<person name="Sinclair D.A."/>
</authorList>
<dbReference type="PubMed" id="12939617"/>
<dbReference type="DOI" id="10.1038/nature01960"/>
</citation>
<scope>ACTIVITY REGULATION</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2004" name="EMBO J." volume="23" first="2369" last="2380">
<title>Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase.</title>
<authorList>
<person name="Frye R.A."/>
<person name="Mayo M.W."/>
</authorList>
<dbReference type="PubMed" id="15152190"/>
<dbReference type="DOI" id="10.1038/sj.emboj.7600244"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2004" name="Cell" volume="116" first="551" last="563">
<title>Mammalian SIRT1 represses forkhead transcription factors.</title>
<authorList>
<person name="Motta M.C."/>
<person name="Divecha N."/>
<person name="Lemieux M."/>
<person name="Kamel C."/>
<person name="Chen D."/>
<person name="Gu W."/>
<person name="Bultsma Y."/>
<person name="McBurney M."/>
<person name="Guarente L."/>
</authorList>
<dbReference type="PubMed" id="14980222"/>
<dbReference type="DOI" id="10.1016/s0092-8674(04)00126-6"/>
</citation>
<scope>FUNCTION IN DEACETYLATION OF FOXO3</scope>
<scope>FUNCTION IN REGULATION OF FOXO3</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="28873" last="28879">
<title>FOXO4 is acetylated upon peroxide stress and deacetylated by the longevity protein hSir2(SIRT1).</title>
<authorList>
<person name="van der Horst A."/>
<person name="Tertoolen L.G.J."/>
<person name="de Vries-Smits L.M.M."/>
<person name="Frye R.A."/>
<person name="Medema R.H."/>
<person name="Burgering B.M.T."/>
</authorList>
<dbReference type="PubMed" id="15126506"/>
<dbReference type="DOI" id="10.1074/jbc.m401138200"/>
</citation>
<scope>FUNCTION IN DEACETYLATION OF MLLT7</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2004" name="Mol. Cell" volume="16" first="93" last="105">
<title>Human SirT1 interacts with histone H1 and promotes formation of facultative heterochromatin.</title>
<authorList>
<person name="Vaquero A."/>
<person name="Scher M."/>
<person name="Lee D."/>
<person name="Erdjument-Bromage H."/>
<person name="Tempst P."/>
<person name="Reinberg D."/>
</authorList>
<dbReference type="PubMed" id="15469825"/>
<dbReference type="DOI" id="10.1016/j.molcel.2004.08.031"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2004" name="Science" volume="303" first="2011" last="2015">
<title>Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase.</title>
<authorList>
<person name="Brunet A."/>
<person name="Sweeney L.B."/>
<person name="Sturgill J.F."/>
<person name="Chua K.F."/>
<person name="Greer P.L."/>
<person name="Lin Y."/>
<person name="Tran H."/>
<person name="Ross S.E."/>
<person name="Mostoslavsky R."/>
<person name="Cohen H.Y."/>
<person name="Hu L.S."/>
<person name="Cheng H.L."/>
<person name="Jedrychowski M.P."/>
<person name="Gygi S.P."/>
<person name="Sinclair D.A."/>
<person name="Alt F.W."/>
<person name="Greenberg M.E."/>
</authorList>
<dbReference type="PubMed" id="14976264"/>
<dbReference type="DOI" id="10.1126/science.1094637"/>
</citation>
<scope>FUNCTION IN DEACETYLATION OF FOXO3</scope>
<scope>FUNCTION IN REGULATION OF FOXO3</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2004" name="Science" volume="305" first="390" last="392">
<title>Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase.</title>
<authorList>
<person name="Cohen H.Y."/>
<person name="Miller C."/>
<person name="Bitterman K.J."/>
<person name="Wall N.R."/>
<person name="Hekking B."/>
<person name="Kessler B."/>
<person name="Howitz K.T."/>
<person name="Gorospe M."/>
<person name="de Cabo R."/>
<person name="Sinclair D.A."/>
</authorList>
<dbReference type="PubMed" id="15205477"/>
<dbReference type="DOI" id="10.1126/science.1099196"/>
</citation>
<scope>FUNCTION IN DEACETYLATION OF XRCC6</scope>
<scope>INDUCTION BY CR</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2005" name="EMBO J." volume="24" first="1021" last="1032">
<title>Suppression of FOXO1 activity by FHL2 through SIRT1-mediated deacetylation.</title>
<authorList>
<person name="Yang Y."/>
<person name="Hou H."/>
<person name="Haller E.M."/>
<person name="Nicosia S.V."/>
<person name="Bai W."/>
</authorList>
<dbReference type="PubMed" id="15692560"/>
<dbReference type="DOI" id="10.1038/sj.emboj.7600570"/>
</citation>
<scope>INTERACTION WITH FHL2</scope>
<scope>FUNCTION IN DEACETYLATION OF FOXO1</scope>
<scope>FUNCTION IN REGULATION OF FOXO1</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2005" name="Mol. Biol. Cell" volume="16" first="4623" last="4635">
<title>Evolutionarily conserved and nonconserved cellular localizations and functions of human SIRT proteins.</title>
<authorList>
<person name="Michishita E."/>
<person name="Park J.Y."/>
<person name="Burneskis J.M."/>
<person name="Barrett J.C."/>
<person name="Horikawa I."/>
</authorList>
<dbReference type="PubMed" id="16079181"/>
<dbReference type="DOI" id="10.1091/mbc.e05-01-0033"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2005" name="Mol. Cell. Biol." volume="25" first="8456" last="8464">
<title>Regulation of MEF2 by histone deacetylase 4- and SIRT1 deacetylase-mediated lysine modifications.</title>
<authorList>
<person name="Zhao X."/>
<person name="Sternsdorf T."/>
<person name="Bolger T.A."/>
<person name="Evans R.M."/>
<person name="Yao T.-P."/>
</authorList>
<dbReference type="PubMed" id="16166628"/>
<dbReference type="DOI" id="10.1128/mcb.25.19.8456-8464.2005"/>
</citation>
<scope>FUNCTION IN DEACETYLATION OF MEF2D</scope>
<scope>INTERACTION WITH HDAC4</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2005" name="PLoS Biol." volume="3" first="210" last="220">
<title>SIRT1 regulates HIV transcription via Tat deacetylation.</title>
<authorList>
<person name="Pagans S."/>
<person name="Pedal A."/>
<person name="North B.J."/>
<person name="Kaehlcke K."/>
<person name="Marshall B.L."/>
<person name="Dorr A."/>
<person name="Hetzer-Egger C."/>
<person name="Henklein P."/>
<person name="Frye R."/>
<person name="McBurney M.W."/>
<person name="Hruby H."/>
<person name="Jung M."/>
<person name="Verdin E."/>
<person name="Ott M."/>
</authorList>
<dbReference type="PubMed" id="15719057"/>
<dbReference type="DOI" id="10.1371/journal.pbio.0030041"/>
</citation>
<scope>INTERACTION WITH HIV-1 TAT (MICROBIAL INFECTION)</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2005" name="Proc. Natl. Acad. Sci. U.S.A." volume="102" first="1859" last="1864">
<title>Composition and histone substrates of polycomb repressive group complexes change during cellular differentiation.</title>
<authorList>
<person name="Kuzmichev A."/>
<person name="Margueron R."/>
<person name="Vaquero A."/>
<person name="Preissner T.S."/>
<person name="Scher M."/>
<person name="Kirmizis A."/>
<person name="Ouyang X."/>
<person name="Brockdorff N."/>
<person name="Abate-Shen C."/>
<person name="Farnham P.J."/>
<person name="Reinberg D."/>
</authorList>
<dbReference type="PubMed" id="15684044"/>
<dbReference type="DOI" id="10.1073/pnas.0409875102"/>
</citation>
<scope>ASSOCIATION WITH THE PRC4 COMPLEX</scope>
<scope>INTERACTION WITH SUZ12</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2006" name="Nat. Biotechnol." volume="24" first="1285" last="1292">
<title>A probability-based approach for high-throughput protein phosphorylation analysis and site localization.</title>
<authorList>
<person name="Beausoleil S.A."/>
<person name="Villen J."/>
<person name="Gerber S.A."/>
<person name="Rush J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="16964243"/>
<dbReference type="DOI" id="10.1038/nbt1240"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-47</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="22">
<citation type="journal article" date="2006" name="Nat. Cell Biol." volume="8" first="1025" last="1031">
<title>Interactions between E2F1 and SirT1 regulate apoptotic response to DNA damage.</title>
<authorList>
<person name="Wang C."/>
<person name="Chen L."/>
<person name="Hou X."/>
<person name="Li Z."/>
<person name="Kabra N."/>
<person name="Ma Y."/>
<person name="Nemoto S."/>
<person name="Finkel T."/>
<person name="Gu W."/>
<person name="Cress W.D."/>
<person name="Chen J."/>
</authorList>
<dbReference type="PubMed" id="16892051"/>
<dbReference type="DOI" id="10.1038/ncb1468"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH E2F1</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2007" name="Biochem. J." volume="407" first="451" last="460">
<title>Deacetylation of the retinoblastoma tumour suppressor protein by SIRT1.</title>
<authorList>
<person name="Wong S."/>
<person name="Weber J.D."/>
</authorList>
<dbReference type="PubMed" id="17620057"/>
<dbReference type="DOI" id="10.1042/bj20070151"/>
</citation>
<scope>FUNCTION IN DEACETYLATION OF RB1</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2007" name="Biochem. J." volume="408" first="105" last="111">
<title>Sirt1 interacts with transducin-like enhancer of split-1 to inhibit nuclear factor kappaB-mediated transcription.</title>
<authorList>
<person name="Ghosh H.S."/>
<person name="Spencer J.V."/>
<person name="Ng B."/>
<person name="McBurney M.W."/>
<person name="Robbins P.D."/>
</authorList>
<dbReference type="PubMed" id="17680780"/>
<dbReference type="DOI" id="10.1042/bj20070817"/>
</citation>
<scope>INTERACTION WITH TLE1</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2007" name="EMBO J." volume="26" first="1081" last="1093">
<title>Distinct C/EBPalpha motifs regulate lipogenic and gluconeogenic gene expression in vivo.</title>
<authorList>
<person name="Pedersen T.A."/>
<person name="Bereshchenko O."/>
<person name="Garcia-Silva S."/>
<person name="Ermakova O."/>
<person name="Kurz E."/>
<person name="Mandrup S."/>
<person name="Porse B.T."/>
<person name="Nerlov C."/>
</authorList>
<dbReference type="PubMed" id="17290224"/>
<dbReference type="DOI" id="10.1038/sj.emboj.7601563"/>
</citation>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF HIS-363</scope>
<scope>ACTIVE SITE</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2007" name="Exp. Mol. Med." volume="39" first="8" last="13">
<title>SIRT1 promotes DNA repair activity and deacetylation of Ku70.</title>
<authorList>
<person name="Jeong J."/>
<person name="Juhn K."/>
<person name="Lee H."/>
<person name="Kim S.H."/>
<person name="Min B.H."/>
<person name="Lee K.M."/>
<person name="Cho M.H."/>
<person name="Park G.H."/>
<person name="Lee K.H."/>
</authorList>
<dbReference type="PubMed" id="17334224"/>
<dbReference type="DOI" id="10.1038/emm.2007.2"/>
</citation>
<scope>FUNCTION IN DEACETYLATION OF XRCC6</scope>
<scope>FUNCTION IN DNA REPAIR</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2007" name="J. Cell. Physiol." volume="210" first="161" last="166">
<title>SIRT1 interacts with p73 and suppresses p73-dependent transcriptional activity.</title>
<authorList>
<person name="Dai J.M."/>
<person name="Wang Z.Y."/>
<person name="Sun D.C."/>
<person name="Lin R.X."/>
<person name="Wang S.Q."/>
</authorList>
<dbReference type="PubMed" id="16998810"/>
<dbReference type="DOI" id="10.1002/jcp.20831"/>
</citation>
<scope>FUNCTION IN DEACETYLATION OF TP73</scope>
<scope>FUNCTION IN REGULATION OF TP73</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2007" name="Mol. Endocrinol." volume="21" first="1807" last="1821">
<title>Sirtuin 1 is required for antagonist-induced transcriptional repression of androgen-responsive genes by the androgen receptor.</title>
<authorList>
<person name="Dai Y."/>
<person name="Ngo D."/>
<person name="Forman L.W."/>
<person name="Qin D.C."/>
<person name="Jacob J."/>
<person name="Faller D.V."/>
</authorList>
<dbReference type="PubMed" id="17505061"/>
<dbReference type="DOI" id="10.1210/me.2006-0467"/>
</citation>
<scope>FUNCTION IN AR-DEPENDENT REPRESSION</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2007" name="Mol. Cell" volume="28" first="277" last="290">
<title>Active regulator of SIRT1 cooperates with SIRT1 and facilitates suppression of p53 activity.</title>
<authorList>
<person name="Kim E.-J."/>
<person name="Kho J.-H."/>
<person name="Kang M.-R."/>
<person name="Um S.-J."/>
</authorList>
<dbReference type="PubMed" id="17964266"/>
<dbReference type="DOI" id="10.1016/j.molcel.2007.08.030"/>
</citation>
<scope>INTERACTION WITH RPS19BP1</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2007" name="Mol. Cell" volume="28" first="513" last="513">
<authorList>
<person name="Kim E.-J."/>
<person name="Kho J.-H."/>
<person name="Kang M.-R."/>
<person name="Um S.-J."/>
</authorList>
</citation>
<scope>ERRATUM OF PUBMED:17964266</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2007" name="Mol. Cell" volume="28" first="91" last="106">
<title>SIRT1 deacetylates and positively regulates the nuclear receptor LXR.</title>
<authorList>
<person name="Li X."/>
<person name="Zhang S."/>
<person name="Blander G."/>
<person name="Tse J.G."/>
<person name="Krieger M."/>
<person name="Guarente L."/>
</authorList>
<dbReference type="PubMed" id="17936707"/>
<dbReference type="DOI" id="10.1016/j.molcel.2007.07.032"/>
</citation>
<scope>FUNCTION IN DEACETYLATION OF NR1H3 AND NR1H2</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2007" name="Mol. Cell" volume="27" first="149" last="162">
<title>SIRT1 regulates the function of the Nijmegen breakage syndrome protein.</title>
<authorList>
<person name="Yuan Z."/>
<person name="Zhang X."/>
<person name="Sengupta N."/>
<person name="Lane W.S."/>
<person name="Seto E."/>
</authorList>
<dbReference type="PubMed" id="17612497"/>
<dbReference type="DOI" id="10.1016/j.molcel.2007.05.029"/>
</citation>
<scope>FUNCTION IN DEACETYLATION OF NBN</scope>
<scope>FUNCTION IN DNA REPAIR</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2007" name="Mol. Cell. Biol." volume="27" first="2661" last="2675">
<title>An acetylation/deacetylation-SUMOylation switch through a phylogenetically conserved psiKXEP motif in the tumor suppressor HIC1 regulates transcriptional repression activity.</title>
<authorList>
<person name="Stankovic-Valentin N."/>
<person name="Deltour S."/>
<person name="Seeler J."/>
<person name="Pinte S."/>
<person name="Vergoten G."/>
<person name="Guerardel C."/>
<person name="Dejean A."/>
<person name="Leprince D."/>
</authorList>
<dbReference type="PubMed" id="17283066"/>
<dbReference type="DOI" id="10.1128/mcb.01098-06"/>
</citation>
<scope>FUNCTION IN DEACETYLATION OF HIC1</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2007" name="Nature" volume="450" first="440" last="444">
<title>SIRT1 regulates the histone methyl-transferase SUV39H1 during heterochromatin formation.</title>
<authorList>
<person name="Vaquero A."/>
<person name="Scher M."/>
<person name="Erdjument-Bromage H."/>
<person name="Tempst P."/>
<person name="Serrano L."/>
<person name="Reinberg D."/>
</authorList>
<dbReference type="PubMed" id="18004385"/>
<dbReference type="DOI" id="10.1038/nature06268"/>
</citation>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF HIS-363</scope>
<scope>ACTIVE SITE</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2008" name="Cell" volume="134" first="317" last="328">
<title>SIRT1 regulates circadian clock gene expression through PER2 deacetylation.</title>
<authorList>
<person name="Asher G."/>
<person name="Gatfield D."/>
<person name="Stratmann M."/>
<person name="Reinke H."/>
<person name="Dibner C."/>
<person name="Kreppel F."/>
<person name="Mostoslavsky R."/>
<person name="Alt F.W."/>
<person name="Schibler U."/>
</authorList>
<dbReference type="PubMed" id="18662546"/>
<dbReference type="DOI" id="10.1016/j.cell.2008.06.050"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2008" name="Cell" volume="133" first="627" last="639">
<title>Epigenetic control of rDNA loci in response to intracellular energy status.</title>
<authorList>
<person name="Murayama A."/>
<person name="Ohmori K."/>
<person name="Fujimura A."/>
<person name="Minami H."/>
<person name="Yasuzawa-Tanaka K."/>
<person name="Kuroda T."/>
<person name="Oie S."/>
<person name="Daitoku H."/>
<person name="Okuwaki M."/>
<person name="Nagata K."/>
<person name="Fukamizu A."/>
<person name="Kimura K."/>
<person name="Shimizu T."/>
<person name="Yanagisawa J."/>
</authorList>
<dbReference type="PubMed" id="18485871"/>
<dbReference type="DOI" id="10.1016/j.cell.2008.03.030"/>
</citation>
<scope>IDENTIFICATION IN THE ENOSC COMPLEX</scope>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF HIS-363</scope>
<scope>ACTIVE SITE</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2008" name="Cell Cycle" volume="7" first="3091" last="3097">
<title>JNK2-dependent regulation of SIRT1 protein stability.</title>
<authorList>
<person name="Ford J."/>
<person name="Ahmed S."/>
<person name="Allison S."/>
<person name="Jiang M."/>
<person name="Milner J."/>
</authorList>
<dbReference type="PubMed" id="18838864"/>
<dbReference type="DOI" id="10.4161/cc.7.19.6799"/>
</citation>
<scope>PHOSPHORYLATION AT SER-27 AND SER-47</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2008" name="Cell Host Microbe" volume="3" first="158" last="167">
<title>Human immunodeficiency virus type 1 Tat protein inhibits the SIRT1 deacetylase and induces T cell hyperactivation.</title>
<authorList>
<person name="Kwon H.S."/>
<person name="Brent M.M."/>
<person name="Getachew R."/>
<person name="Jayakumar P."/>
<person name="Chen L.F."/>
<person name="Schnolzer M."/>
<person name="McBurney M.W."/>
<person name="Marmorstein R."/>
<person name="Greene W.C."/>
<person name="Ott M."/>
</authorList>
<dbReference type="PubMed" id="18329615"/>
<dbReference type="DOI" id="10.1016/j.chom.2008.02.002"/>
</citation>
<scope>INTERACTION WITH HIV-1 TAT (MICROBIAL INFECTION)</scope>
<scope>FUNCTION IN T-CELL ACTIVATION (MICROBIAL INFECTION)</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2008" name="J. Biol. Chem." volume="283" first="7590" last="7598">
<title>Regulation of WRN protein cellular localization and enzymatic activities by SIRT1-mediated deacetylation.</title>
<authorList>
<person name="Li K."/>
<person name="Casta A."/>
<person name="Wang R."/>
<person name="Lozada E."/>
<person name="Fan W."/>
<person name="Kane S."/>
<person name="Ge Q."/>
<person name="Gu W."/>
<person name="Orren D."/>
<person name="Luo J."/>
</authorList>
<dbReference type="PubMed" id="18203716"/>
<dbReference type="DOI" id="10.1074/jbc.m709707200"/>
</citation>
<scope>FUNCTION IN DEACETYLATION OF WRN</scope>
<scope>FUNCTION IN DNA DAMAGE</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2008" name="J. Biol. Chem." volume="283" first="27628" last="27635">
<title>SIRT1 modulation of the acetylation status, cytosolic localization, and activity of LKB1. Possible role in AMP-activated protein kinase activation.</title>
<authorList>
<person name="Lan F."/>
<person name="Cacicedo J.M."/>
<person name="Ruderman N."/>
<person name="Ido Y."/>
</authorList>
<dbReference type="PubMed" id="18687677"/>
<dbReference type="DOI" id="10.1074/jbc.m805711200"/>
</citation>
<scope>FUNCTION IN DEACETYLATION OF STK11</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2008" name="Nature" volume="451" first="583" last="586">
<title>DBC1 is a negative regulator of SIRT1.</title>
<authorList>
<person name="Kim J.-E."/>
<person name="Chen J."/>
<person name="Lou Z."/>
</authorList>
<dbReference type="PubMed" id="18235501"/>
<dbReference type="DOI" id="10.1038/nature06500"/>
</citation>
<scope>INTERACTION WITH CCAR2</scope>
<scope>ACTIVITY REGULATION</scope>
<scope>MUTAGENESIS OF HIS-363</scope>
<scope>ACTIVE SITE</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2008" name="Nature" volume="451" first="587" last="590">
<title>Negative regulation of the deacetylase SIRT1 by DBC1.</title>
<authorList>
<person name="Zhao W."/>
<person name="Kruse J.-P."/>
<person name="Tang Y."/>
<person name="Jung S.Y."/>
<person name="Qin J."/>
<person name="Gu W."/>
</authorList>
<dbReference type="PubMed" id="18235502"/>
<dbReference type="DOI" id="10.1038/nature06515"/>
</citation>
<scope>INTERACTION WITH CCAR2</scope>
<scope>ACTIVITY REGULATION</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2008" name="PLoS ONE" volume="3" first="E4020" last="E4020">
<title>Phosphorylation regulates SIRT1 function.</title>
<authorList>
<person name="Sasaki T."/>
<person name="Maier B."/>
<person name="Koclega K.D."/>
<person name="Chruszcz M."/>
<person name="Gluba W."/>
<person name="Stukenberg P.T."/>
<person name="Minor W."/>
<person name="Scrable H."/>
</authorList>
<dbReference type="PubMed" id="19107194"/>
<dbReference type="DOI" id="10.1371/journal.pone.0004020"/>
</citation>
<scope>PHOSPHORYLATION AT SER-14; SER-26; SER-27; SER-47; SER-159; SER-162; SER-172; SER-173; THR-530; THR-544; SER-545; THR-719 AND SER-747</scope>
<scope>MUTAGENESIS OF THR-530 AND SER-540</scope>
</reference>
<reference key="44">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-719</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="45">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="3374" last="3379">
<title>A role for the NAD-dependent deacetylase Sirt1 in the regulation of autophagy.</title>
<authorList>
<person name="Lee I.H."/>
<person name="Cao L."/>
<person name="Mostoslavsky R."/>
<person name="Lombard D.B."/>
<person name="Liu J."/>
<person name="Bruns N.E."/>
<person name="Tsokos M."/>
<person name="Alt F.W."/>
<person name="Finkel T."/>
</authorList>
<dbReference type="PubMed" id="18296641"/>
<dbReference type="DOI" id="10.1073/pnas.0712145105"/>
</citation>
<scope>FUNCTION IN DEACETYLATION OF ATG5; ATG7 AND MAP1LC3B</scope>
<scope>FUNCTION IN AUTOPHAGY</scope>
</reference>
<reference key="46">
<citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
<title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
<authorList>
<person name="Gauci S."/>
<person name="Helbig A.O."/>
<person name="Slijper M."/>
<person name="Krijgsveld J."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="19413330"/>
<dbReference type="DOI" id="10.1021/ac9004309"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="47">
<citation type="journal article" date="2009" name="Biochem. Biophys. Res. Commun." volume="381" first="372" last="377">
<title>Carboxy-terminal phosphorylation of SIRT1 by protein kinase CK2.</title>
<authorList>
<person name="Zschoernig B."/>
<person name="Mahlknecht U."/>
</authorList>
<dbReference type="PubMed" id="19236849"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2009.02.085"/>
</citation>
<scope>PHOSPHORYLATION AT SER-659 AND SER-661</scope>
<scope>MUTAGENESIS OF SER-659; SER-661 AND SER-684</scope>
</reference>
<reference key="48">
<citation type="journal article" date="2009" name="Biochemistry" volume="48" first="2878" last="2890">
<title>Investigating the ADP-ribosyltransferase activity of sirtuins with NAD analogues and 32P-NAD.</title>
<authorList>
<person name="Du J."/>
<person name="Jiang H."/>
<person name="Lin H."/>
</authorList>
<dbReference type="PubMed" id="19220062"/>
<dbReference type="DOI" id="10.1021/bi802093g"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="49">
<citation type="journal article" date="2009" name="Cell Metab." volume="9" first="327" last="338">
<title>Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation.</title>
<authorList>
<person name="Purushotham A."/>
<person name="Schug T.T."/>
<person name="Xu Q."/>
<person name="Surapureddi S."/>
<person name="Guo X."/>
<person name="Li X."/>
</authorList>
<dbReference type="PubMed" id="19356714"/>
<dbReference type="DOI" id="10.1016/j.cmet.2009.02.006"/>
</citation>
<scope>INTERACTION WITH PPARA</scope>
</reference>
<reference key="50">
<citation type="journal article" date="2009" name="J. Biol. Chem." volume="284" first="28762" last="28774">
<title>Transcriptional corepressor SMILE recruits SIRT1 to inhibit nuclear receptor estrogen receptor-related receptor gamma transactivation.</title>
<authorList>
<person name="Xie Y.B."/>
<person name="Park J.H."/>
<person name="Kim D.K."/>
<person name="Hwang J.H."/>
<person name="Oh S."/>
<person name="Park S.B."/>
<person name="Shong M."/>
<person name="Lee I.K."/>
<person name="Choi H.S."/>
</authorList>
<dbReference type="PubMed" id="19690166"/>
<dbReference type="DOI" id="10.1074/jbc.m109.034165"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH CREBZF</scope>
</reference>
<reference key="51">
<citation type="journal article" date="2009" name="J. Cell Biol." volume="185" first="203" last="211">
<title>A c-Myc-SIRT1 feedback loop regulates cell growth and transformation.</title>
<authorList>
<person name="Yuan J."/>
<person name="Minter-Dykhouse K."/>
<person name="Lou Z."/>
</authorList>
<dbReference type="PubMed" id="19364925"/>
<dbReference type="DOI" id="10.1083/jcb.200809167"/>
</citation>
<scope>FUNCTION IN DEACETYLATION OF MYC</scope>
<scope>FUNCTION IN REGULATION OF MYC</scope>
</reference>
<reference key="52">
<citation type="journal article" date="2009" name="Mol. Cell. Biol." volume="29" first="1989" last="1998">
<title>hSirT1-dependent regulation of the PCAF-E2F1-p73 apoptotic pathway in response to DNA damage.</title>
<authorList>
<person name="Pediconi N."/>
<person name="Guerrieri F."/>
<person name="Vossio S."/>
<person name="Bruno T."/>
<person name="Belloni L."/>
<person name="Schinzari V."/>
<person name="Scisciani C."/>
<person name="Fanciulli M."/>
<person name="Levrero M."/>
</authorList>
<dbReference type="PubMed" id="19188449"/>
<dbReference type="DOI" id="10.1128/mcb.00552-08"/>
</citation>
<scope>FUNCTION IN DEACETYLATION OF PCAF</scope>
<scope>FUNCTION IN DNA REPAIR</scope>
</reference>
<reference key="53">
<citation type="journal article" date="2009" name="PLoS ONE" volume="4" first="E8414" last="E8414">
<title>JNK1 phosphorylates SIRT1 and promotes its enzymatic activity.</title>
<authorList>
<person name="Nasrin N."/>
<person name="Kaushik V.K."/>
<person name="Fortier E."/>
<person name="Wall D."/>
<person name="Pearson K.J."/>
<person name="de Cabo R."/>
<person name="Bordone L."/>
</authorList>
<dbReference type="PubMed" id="20027304"/>
<dbReference type="DOI" id="10.1371/journal.pone.0008414"/>
</citation>
<scope>PHOSPHORYLATION AT SER-27; SER-47 AND THR-530</scope>
<scope>MUTAGENESIS OF SER-27; SER-47 AND THR-530</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="54">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-530; SER-535 AND THR-719</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="55">
<citation type="journal article" date="2010" name="Circ. Res." volume="106" first="1384" last="1393">
<title>SIRT1 promotes proliferation and prevents senescence through targeting LKB1 in primary porcine aortic endothelial cells.</title>
<authorList>
<person name="Zu Y."/>
<person name="Liu L."/>
<person name="Lee M.Y."/>
<person name="Xu C."/>
<person name="Liang Y."/>
<person name="Man R.Y."/>
<person name="Vanhoutte P.M."/>
<person name="Wang Y."/>
</authorList>
<dbReference type="PubMed" id="20203304"/>
<dbReference type="DOI" id="10.1161/circresaha.109.215483"/>
</citation>
<scope>FUNCTION IN REGULATION OF STK11</scope>
</reference>
<reference key="56">
<citation type="journal article" date="2010" name="DNA Repair" volume="9" first="383" last="393">
<title>Role of SIRT1 in homologous recombination.</title>
<authorList>
<person name="Uhl M."/>
<person name="Csernok A."/>
<person name="Aydin S."/>
<person name="Kreienberg R."/>
<person name="Wiesmuller L."/>
<person name="Gatz S.A."/>
</authorList>
<dbReference type="PubMed" id="20097625"/>
<dbReference type="DOI" id="10.1016/j.dnarep.2009.12.020"/>
</citation>
<scope>FUNCTION IN DNA REPAIR HOMOLOGOUS RECOMBINATION</scope>
</reference>
<reference key="57">
<citation type="journal article" date="2010" name="J. Biol. Chem." volume="285" first="7097" last="7110">
<title>SIRT1 suppresses activator protein-1 transcriptional activity and cyclooxygenase-2 expression in macrophages.</title>
<authorList>
<person name="Zhang R."/>
<person name="Chen H.Z."/>
<person name="Liu J.J."/>
<person name="Jia Y.Y."/>
<person name="Zhang Z.Q."/>
<person name="Yang R.F."/>
<person name="Zhang Y."/>
<person name="Xu J."/>
<person name="Wei Y.S."/>
<person name="Liu D.P."/>
<person name="Liang C.C."/>
</authorList>
<dbReference type="PubMed" id="20042607"/>
<dbReference type="DOI" id="10.1074/jbc.m109.038604"/>
</citation>
<scope>INTERACTION WITH FOS AND JUN</scope>
</reference>
<reference key="58">
<citation type="journal article" date="2010" name="J. Biol. Chem." volume="285" first="11458" last="11464">
<title>SIRT1 regulates autoacetylation and histone acetyltransferase activity of TIP60.</title>
<authorList>
<person name="Wang J."/>
<person name="Chen J."/>
</authorList>
<dbReference type="PubMed" id="20100829"/>
<dbReference type="DOI" id="10.1074/jbc.m109.087585"/>
</citation>
<scope>FUNCTION IN DEACETYLATION OF KAT5</scope>
</reference>
<reference key="59">
<citation type="journal article" date="2010" name="J. Biol. Chem." volume="285" first="13223" last="13232">
<title>DYRK1A and DYRK3 promote cell survival through phosphorylation and activation of SIRT1.</title>
<authorList>
<person name="Guo X."/>
<person name="Williams J.G."/>
<person name="Schug T.T."/>
<person name="Li X."/>
</authorList>
<dbReference type="PubMed" id="20167603"/>
<dbReference type="DOI" id="10.1074/jbc.m110.102574"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="60">
<citation type="journal article" date="2010" name="J. Biol. Chem." volume="285" first="33959" last="33970">
<title>SIRT1 deacetylates and inhibits SREBP-1C activity in regulation of hepatic lipid metabolism.</title>
<authorList>
<person name="Ponugoti B."/>
<person name="Kim D.H."/>
<person name="Xiao Z."/>
<person name="Smith Z."/>
<person name="Miao J."/>
<person name="Zang M."/>
<person name="Wu S.Y."/>
<person name="Chiang C.M."/>
<person name="Veenstra T.D."/>
<person name="Kemper J.K."/>
</authorList>
<dbReference type="PubMed" id="20817729"/>
<dbReference type="DOI" id="10.1074/jbc.m110.122978"/>
</citation>
<scope>FUNCTION IN DEACETYLATION OF SREBF1</scope>
</reference>
<reference key="61">
<citation type="journal article" date="2010" name="Mol. Cell" volume="38" first="864" last="878">
<title>Sirtuin 1 modulates cellular responses to hypoxia by deacetylating hypoxia-inducible factor 1alpha.</title>
<authorList>
<person name="Lim J.H."/>
<person name="Lee Y.M."/>
<person name="Chun Y.S."/>
<person name="Chen J."/>
<person name="Kim J.E."/>
<person name="Park J.W."/>
</authorList>
<dbReference type="PubMed" id="20620956"/>
<dbReference type="DOI" id="10.1016/j.molcel.2010.05.023"/>
</citation>
<scope>FUNCTION IN DEACETYLATION OF HIF1A</scope>
<scope>FUNCTION IN REGULATION OF HIF1A</scope>
</reference>
<reference key="62">
<citation type="journal article" date="2010" name="Mol. Cell" volume="39" first="247" last="258">
<title>SIRT1 regulates UV-induced DNA repair through deacetylating XPA.</title>
<authorList>
<person name="Fan W."/>
<person name="Luo J."/>
</authorList>
<dbReference type="PubMed" id="20670893"/>
<dbReference type="DOI" id="10.1016/j.molcel.2010.07.006"/>
</citation>
<scope>FUNCTION IN DEACETYLATION OF XPA</scope>
</reference>
<reference key="63">
<citation type="journal article" date="2010" name="Nucleic Acids Res." volume="38" first="832" last="845">
<title>SIRT1 deacetylates APE1 and regulates cellular base excision repair.</title>
<authorList>
<person name="Yamamori T."/>
<person name="DeRicco J."/>
<person name="Naqvi A."/>
<person name="Hoffman T.A."/>
<person name="Mattagajasingh I."/>
<person name="Kasuno K."/>
<person name="Jung S.B."/>
<person name="Kim C.S."/>
<person name="Irani K."/>
</authorList>
<dbReference type="PubMed" id="19934257"/>
<dbReference type="DOI" id="10.1093/nar/gkp1039"/>
</citation>
<scope>FUNCTION IN DEACETYLATION OF APEX1</scope>
<scope>FUNCTION IN DNA REPAIR</scope>
<scope>MUTAGENESIS OF HIS-363</scope>
<scope>ACTIVE SITE</scope>
<scope>INDUCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="64">
<citation type="journal article" date="2010" name="Nucleic Acids Res." volume="38" first="4607" last="4619">
<title>Transcriptional corepressor SHP recruits SIRT1 histone deacetylase to inhibit LRH-1 transactivation.</title>
<authorList>
<person name="Chanda D."/>
<person name="Xie Y.B."/>
<person name="Choi H.S."/>
</authorList>
<dbReference type="PubMed" id="20375098"/>
<dbReference type="DOI" id="10.1093/nar/gkq227"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH NR0B2</scope>
</reference>
<reference key="65">
<citation type="journal article" date="2010" name="PLoS ONE" volume="5" first="E9199" last="E9199">
<title>SIRT1 negatively regulates the mammalian target of rapamycin.</title>
<authorList>
<person name="Ghosh H.S."/>
<person name="McBurney M."/>
<person name="Robbins P.D."/>
</authorList>
<dbReference type="PubMed" id="20169165"/>
<dbReference type="DOI" id="10.1371/journal.pone.0009199"/>
</citation>
<scope>INTERACTION WITH TSC2</scope>
</reference>
<reference key="66">
<citation type="journal article" date="2010" name="PLoS ONE" volume="5" first="E13502" last="E13502">
<title>SIRT1 undergoes alternative splicing in a novel auto-regulatory loop with p53.</title>
<authorList>
<person name="Lynch C.J."/>
<person name="Shah Z.H."/>
<person name="Allison S.J."/>
<person name="Ahmed S.U."/>
<person name="Ford J."/>
<person name="Warnock L.J."/>
<person name="Li H."/>
<person name="Serrano M."/>
<person name="Milner J."/>
</authorList>
<dbReference type="PubMed" id="20975832"/>
<dbReference type="DOI" id="10.1371/journal.pone.0013502"/>
</citation>
<scope>ALTERNATIVE SPLICING (ISOFORM 2)</scope>
<scope>FUNCTION (ISOFORM 2)</scope>
<scope>INDUCTION (ISOFORM 2)</scope>
<scope>INTERACTION WITH TP53 AND RPS19BP1</scope>
</reference>
<reference key="67">
<citation type="journal article" date="2010" name="Proc. Natl. Acad. Sci. U.S.A." volume="107" first="22623" last="22628">
<title>Regulation of global genome nucleotide excision repair by SIRT1 through xeroderma pigmentosum C.</title>
<authorList>
<person name="Ming M."/>
<person name="Shea C.R."/>
<person name="Guo X."/>
<person name="Li X."/>
<person name="Soltani K."/>
<person name="Han W."/>
<person name="He Y.Y."/>
</authorList>
<dbReference type="PubMed" id="21149730"/>
<dbReference type="DOI" id="10.1073/pnas.1010377108"/>
</citation>
<scope>FUNCTION IN DNA REPAIR</scope>
<scope>SUPPRESSION OF XPC</scope>
</reference>
<reference key="68">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2</scope>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-14 AND SER-47</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="69">
<citation type="journal article" date="2011" name="Aging (Albany NY)" volume="3" first="635" last="642">
<title>SIRT1 and SIRT3 deacetylate homologous substrates: AceCS1,2 and HMGCS1,2.</title>
<authorList>
<person name="Hirschey M.D."/>
<person name="Shimazu T."/>
<person name="Capra J.A."/>
<person name="Pollard K.S."/>
<person name="Verdin E."/>
</authorList>
<dbReference type="PubMed" id="21701047"/>
<dbReference type="DOI" id="10.18632/aging.100339"/>
</citation>
<scope>FUNCTION IN DEACETYLATION OF HMGCS1</scope>
</reference>
<reference key="70">
<citation type="journal article" date="2011" name="Arthritis Rheum." volume="63" first="2363" last="2373">
<title>Tumor necrosis factor alpha-mediated cleavage and inactivation of SirT1 in human osteoarthritic chondrocytes.</title>
<authorList>
<person name="Dvir-Ginzberg M."/>
<person name="Gagarina V."/>
<person name="Lee E.J."/>
<person name="Booth R."/>
<person name="Gabay O."/>
<person name="Hall D.J."/>
</authorList>
<dbReference type="PubMed" id="21305533"/>
<dbReference type="DOI" id="10.1002/art.30279"/>
</citation>
<scope>PROCESSING</scope>
</reference>
<reference key="71">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="72">
<citation type="journal article" date="2011" name="Biochem. J." volume="433" first="245" last="252">
<title>Regulation of unfolded protein response modulator XBP1s by acetylation and deacetylation.</title>
<authorList>
<person name="Wang F.M."/>
<person name="Chen Y.J."/>
<person name="Ouyang H.J."/>
</authorList>
<dbReference type="PubMed" id="20955178"/>
<dbReference type="DOI" id="10.1042/bj20101293"/>
</citation>
<scope>FUNCTION IN DEACETYLATION OF XBP1</scope>
<scope>INTERACTION WITH XBP1</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="73">
<citation type="journal article" date="2011" name="Biochim. Biophys. Acta" volume="1809" first="269" last="275">
<title>EVI1 up-regulates the stress responsive gene SIRT1 which triggers deacetylation and degradation of EVI1.</title>
<authorList>
<person name="Pradhan A.K."/>
<person name="Kuila N."/>
<person name="Singh S."/>
<person name="Chakraborty S."/>
</authorList>
<dbReference type="PubMed" id="21555002"/>
<dbReference type="DOI" id="10.1016/j.bbagrm.2011.04.007"/>
</citation>
<scope>FUNCTION IN DEACETYLATION OF MECOM</scope>
</reference>
<reference key="74">
<citation type="journal article" date="2011" name="Biochem. Pharmacol." volume="82" first="2008" last="2015">
<title>Energy sensing factors PGC-1alpha and SIRT1 modulate PXR expression and function.</title>
<authorList>
<person name="Buler M."/>
<person name="Aatsinki S.M."/>
<person name="Skoumal R."/>
<person name="Hakkola J."/>
</authorList>
<dbReference type="PubMed" id="21933665"/>
<dbReference type="DOI" id="10.1016/j.bcp.2011.09.006"/>
</citation>
<scope>INTERACTION WITH NR1I2</scope>
</reference>
<reference key="75">
<citation type="journal article" date="2011" name="Int. J. Biochem. Cell Biol." volume="43" first="1573" last="1581">
<title>Sirt1 deacetylates c-Myc and promotes c-Myc/Max association.</title>
<authorList>
<person name="Mao B."/>
<person name="Zhao G."/>
<person name="Lv X."/>
<person name="Chen H.Z."/>
<person name="Xue Z."/>
<person name="Yang B."/>
<person name="Liu D.P."/>
<person name="Liang C.C."/>
</authorList>
<dbReference type="PubMed" id="21807113"/>
<dbReference type="DOI" id="10.1016/j.biocel.2011.07.006"/>
</citation>
<scope>FUNCTION IN DEACETYLATION OF MYC</scope>
<scope>FUNCTION IN REGULATION OF MYC</scope>
</reference>
<reference key="76">
<citation type="journal article" date="2011" name="J. Biol. Chem." volume="286" first="6940" last="6945">
<title>MST1 promotes apoptosis through regulating Sirt1-dependent p53 deacetylation.</title>
<authorList>
<person name="Yuan F."/>
<person name="Xie Q."/>
<person name="Wu J."/>
<person name="Bai Y."/>
<person name="Mao B."/>
<person name="Dong Y."/>
<person name="Bi W."/>
<person name="Ji G."/>
<person name="Tao W."/>
<person name="Wang Y."/>
<person name="Yuan Z."/>
</authorList>
<dbReference type="PubMed" id="21212262"/>
<dbReference type="DOI" id="10.1074/jbc.m110.182543"/>
</citation>
<scope>PHOSPHORYLATION BY STK4/MST1</scope>
</reference>
<reference key="77">
<citation type="journal article" date="2011" name="J. Biol. Chem." volume="286" first="19100" last="19108">
<title>Cancer cell survival following DNA damage-mediated premature senescence is regulated by mammalian target of rapamycin (mTOR)-dependent Inhibition of sirtuin 1.</title>
<authorList>
<person name="Back J.H."/>
<person name="Rezvani H.R."/>
<person name="Zhu Y."/>
<person name="Guyonnet-Duperat V."/>
<person name="Athar M."/>
<person name="Ratner D."/>
<person name="Kim A.L."/>
</authorList>
<dbReference type="PubMed" id="21471201"/>
<dbReference type="DOI" id="10.1074/jbc.m111.240598"/>
</citation>
<scope>FUNCTION IN APOPTOSIS</scope>
<scope>PHOSPHORYLATION AT SER-47</scope>
<scope>MUTAGENESIS OF SER-47 AND PHE-474</scope>
</reference>
<reference key="78">
<citation type="journal article" date="2011" name="Mol. Cell" volume="42" first="210" last="223">
<title>Stabilization of Suv39H1 by SirT1 is part of oxidative stress response and ensures genome protection.</title>
<authorList>
<person name="Bosch-Presegue L."/>
<person name="Raurell-Vila H."/>
<person name="Marazuela-Duque A."/>
<person name="Kane-Goldsmith N."/>
<person name="Valle A."/>
<person name="Oliver J."/>
<person name="Serrano L."/>
<person name="Vaquero A."/>
</authorList>
<dbReference type="PubMed" id="21504832"/>
<dbReference type="DOI" id="10.1016/j.molcel.2011.02.034"/>
</citation>
<scope>FUNCTION IN STABILIZATION OF SUV39H1</scope>
</reference>
<reference key="79">
<citation type="journal article" date="2011" name="Mol. Cell. Biol." volume="31" first="4720" last="4734">
<title>SIRT1 deacetylates the DNA methyltransferase 1 (DNMT1) protein and alters its activities.</title>
<authorList>
<person name="Peng L."/>
<person name="Yuan Z."/>
<person name="Ling H."/>
<person name="Fukasawa K."/>
<person name="Robertson K."/>
<person name="Olashaw N."/>
<person name="Koomen J."/>
<person name="Chen J."/>
<person name="Lane W.S."/>
<person name="Seto E."/>
</authorList>
<dbReference type="PubMed" id="21947282"/>
<dbReference type="DOI" id="10.1128/mcb.06147-11"/>
</citation>
<scope>FUNCTION IN DEACETYLATION OF DNMT1</scope>
<scope>FUNCTION IN REGULATION OF DNMT1</scope>
</reference>
<reference key="80">
<citation type="journal article" date="2011" name="PLoS Genet." volume="7" first="E1002135" last="E1002135">
<title>SIRT1 promotes N-Myc oncogenesis through a positive feedback loop involving the effects of MKP3 and ERK on N-Myc protein stability.</title>
<authorList>
<person name="Marshall G.M."/>
<person name="Liu P.Y."/>
<person name="Gherardi S."/>
<person name="Scarlett C.J."/>
<person name="Bedalov A."/>
<person name="Xu N."/>
<person name="Iraci N."/>
<person name="Valli E."/>
<person name="Ling D."/>
<person name="Thomas W."/>
<person name="van Bekkum M."/>
<person name="Sekyere E."/>
<person name="Jankowski K."/>
<person name="Trahair T."/>
<person name="Mackenzie K.L."/>
<person name="Haber M."/>
<person name="Norris M.D."/>
<person name="Biankin A.V."/>
<person name="Perini G."/>
<person name="Liu T."/>
</authorList>
<dbReference type="PubMed" id="21698133"/>
<dbReference type="DOI" id="10.1371/journal.pgen.1002135"/>
</citation>
<scope>FUNCTION IN REGULATION OF MYCN</scope>
<scope>INTERACTION WITH MYCN</scope>
</reference>
<reference key="81">
<citation type="journal article" date="2011" name="PLoS Genet." volume="7" first="E1002235" last="E1002235">
<title>The evolutionarily conserved longevity determinants HCF-1 and SIR-2.1/SIRT1 collaborate to regulate DAF-16/FOXO.</title>
<authorList>
<person name="Rizki G."/>
<person name="Iwata T.N."/>
<person name="Li J."/>
<person name="Riedel C.G."/>
<person name="Picard C.L."/>
<person name="Jan M."/>
<person name="Murphy C.T."/>
<person name="Lee S.S."/>
</authorList>
<dbReference type="PubMed" id="21909281"/>
<dbReference type="DOI" id="10.1371/journal.pgen.1002235"/>
</citation>
<scope>INTERACTION WITH HCFC1</scope>
</reference>
<reference key="82">
<citation type="journal article" date="2011" name="Proc. Natl. Acad. Sci. U.S.A." volume="108" first="1925" last="1930">
<title>Methyltransferase Set7/9 regulates p53 activity by interacting with Sirtuin 1 (SIRT1).</title>
<authorList>
<person name="Liu X."/>
<person name="Wang D."/>
<person name="Zhao Y."/>
<person name="Tu B."/>
<person name="Zheng Z."/>
<person name="Wang L."/>
<person name="Wang H."/>
<person name="Gu W."/>
<person name="Roeder R.G."/>
<person name="Zhu W.G."/>
</authorList>
<dbReference type="PubMed" id="21245319"/>
<dbReference type="DOI" id="10.1073/pnas.1019619108"/>
</citation>
<scope>INTERACTION WITH SETD7</scope>
<scope>METHYLATION</scope>
<scope>MUTAGENESIS OF LYS-233; LYS-235; LYS-236 AND LYS-238</scope>
</reference>
<reference key="83">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RA46" last="RA46">
<title>The deacetylase SIRT1 promotes membrane localization and activation of Akt and PDK1 during tumorigenesis and cardiac hypertrophy.</title>
<authorList>
<person name="Sundaresan N.R."/>
<person name="Pillai V.B."/>
<person name="Wolfgeher D."/>
<person name="Samant S."/>
<person name="Vasudevan P."/>
<person name="Parekh V."/>
<person name="Raghuraman H."/>
<person name="Cunningham J.M."/>
<person name="Gupta M."/>
<person name="Gupta M.P."/>
</authorList>
<dbReference type="PubMed" id="21775285"/>
<dbReference type="DOI" id="10.1126/scisignal.2001465"/>
</citation>
<scope>FUNCTION IN DEACETYLATION OF AKT1</scope>
<scope>FUNCTION IN REGULATION OF AKT1</scope>
</reference>
<reference key="84">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2</scope>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-14; SER-47 AND THR-719</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="85">
<citation type="journal article" date="2012" name="Arthritis Rheum." volume="64" first="718" last="728">
<title>75kDa SirT1 blocks TNFalpha-mediated apoptosis in human osteoarthritic chondrocytes.</title>
<authorList>
<person name="Oppenheimer H."/>
<person name="Gabay O."/>
<person name="Meir H."/>
<person name="Haze A."/>
<person name="Kandel L."/>
<person name="Liebergall M."/>
<person name="Gagarina V."/>
<person name="Lee E.J."/>
<person name="Dvir-Ginzberg M."/>
</authorList>
<dbReference type="PubMed" id="21987377"/>
<dbReference type="DOI" id="10.1002/art.33407"/>
</citation>
<scope>FUNCTION (SIRTT1 75 KDA FRAGMENT)</scope>
<scope>SUBCELLULAR LOCATION (75SIRT1)</scope>
</reference>
<reference key="86">
<citation type="journal article" date="2011" name="Nucleic Acids Res." volume="39" first="9549" last="9558">
<title>SIRT1 links CIITA deacetylation to MHC II activation.</title>
<authorList>
<person name="Wu X."/>
<person name="Kong X."/>
<person name="Chen D."/>
<person name="Li H."/>
<person name="Zhao Y."/>
<person name="Xia M."/>
<person name="Fang M."/>
<person name="Li P."/>
<person name="Fang F."/>
<person name="Sun L."/>
<person name="Tian W."/>
<person name="Xu H."/>
<person name="Yang Y."/>
<person name="Qi X."/>
<person name="Gao Y."/>
<person name="Sha J."/>
<person name="Chen Q."/>
<person name="Xu Y."/>
</authorList>
<dbReference type="PubMed" id="21890893"/>
<dbReference type="DOI" id="10.1093/nar/gkr651"/>
</citation>
<scope>FUNCTION IN DEACETYLATION OF CIITA</scope>
</reference>
<reference key="87">
<citation type="journal article" date="2012" name="EMBO J." volume="31" first="1427" last="1439">
<title>PML regulates PER2 nuclear localization and circadian function.</title>
<authorList>
<person name="Miki T."/>
<person name="Xu Z."/>
<person name="Chen-Goodspeed M."/>
<person name="Liu M."/>
<person name="Van Oort-Jansen A."/>
<person name="Rea M.A."/>
<person name="Zhao Z."/>
<person name="Lee C.C."/>
<person name="Chang K.S."/>
</authorList>
<dbReference type="PubMed" id="22274616"/>
<dbReference type="DOI" id="10.1038/emboj.2012.1"/>
</citation>
<scope>FUNCTION IN DEACETYLATION OF PML</scope>
</reference>
<reference key="88">
<citation type="journal article" date="2012" name="Mol. Cell. Proteomics" volume="11" first="M111.015131" last="M111.015131">
<title>Comparative large-scale characterisation of plant vs. mammal proteins reveals similar and idiosyncratic N-alpha acetylation features.</title>
<authorList>
<person name="Bienvenut W.V."/>
<person name="Sumpton D."/>
<person name="Martinez A."/>
<person name="Lilla S."/>
<person name="Espagne C."/>
<person name="Meinnel T."/>
<person name="Giglione C."/>
</authorList>
<dbReference type="PubMed" id="22223895"/>
<dbReference type="DOI" id="10.1074/mcp.m111.015131"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="89">
<citation type="journal article" date="2012" name="Oncogene" volume="31" first="1546" last="1557">
<title>Deacetylation of FOXO3 by SIRT1 or SIRT2 leads to Skp2-mediated FOXO3 ubiquitination and degradation.</title>
<authorList>
<person name="Wang F."/>
<person name="Chan C.H."/>
<person name="Chen K."/>
<person name="Guan X."/>
<person name="Lin H.K."/>
<person name="Tong Q."/>
</authorList>
<dbReference type="PubMed" id="21841822"/>
<dbReference type="DOI" id="10.1038/onc.2011.347"/>
</citation>
<scope>FUNCTION IN DEACETYLATION OF FOXO3</scope>
<scope>FUNCTION IN REGULATION OF FOXO3</scope>
</reference>
<reference key="90">
<citation type="journal article" date="2012" name="Proc. Natl. Acad. Sci. U.S.A." volume="109" first="12449" last="12454">
<title>N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB.</title>
<authorList>
<person name="Van Damme P."/>
<person name="Lasa M."/>
<person name="Polevoda B."/>
<person name="Gazquez C."/>
<person name="Elosegui-Artola A."/>
<person name="Kim D.S."/>
<person name="De Juan-Pardo E."/>
<person name="Demeyer K."/>
<person name="Hole K."/>
<person name="Larrea E."/>
<person name="Timmerman E."/>
<person name="Prieto J."/>
<person name="Arnesen T."/>
<person name="Sherman F."/>
<person name="Gevaert K."/>
<person name="Aldabe R."/>
</authorList>
<dbReference type="PubMed" id="22814378"/>
<dbReference type="DOI" id="10.1073/pnas.1210303109"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="91">
<citation type="journal article" date="2013" name="Cancer Lett." volume="333" first="180" last="186">
<title>Deleted in breast cancer 1 (DBC1) deficiency results in apoptosis of breast cancer cells through impaired responses to UV-induced DNA damage.</title>
<authorList>
<person name="Kim W."/>
<person name="Kim J.E."/>
</authorList>
<dbReference type="PubMed" id="23352644"/>
<dbReference type="DOI" id="10.1016/j.canlet.2013.01.026"/>
</citation>
<scope>INTERACTION WITH CCAR2</scope>
</reference>
<reference key="92">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-14; SER-27; SER-47 AND THR-719</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="93">
<citation type="journal article" date="2013" name="Mol. Cell. Biol." volume="33" first="4552" last="4561">
<title>SIRT4 represses peroxisome proliferator-activated receptor alpha activity to suppress hepatic fat oxidation.</title>
<authorList>
<person name="Laurent G."/>
<person name="de Boer V.C."/>
<person name="Finley L.W."/>
<person name="Sweeney M."/>
<person name="Lu H."/>
<person name="Schug T.T."/>
<person name="Cen Y."/>
<person name="Jeong S.M."/>
<person name="Li X."/>
<person name="Sauve A.A."/>
<person name="Haigis M.C."/>
</authorList>
<dbReference type="PubMed" id="24043310"/>
<dbReference type="DOI" id="10.1128/mcb.00087-13"/>
</citation>
<scope>INTERACTION WITH PPARA</scope>
</reference>
<reference key="94">
<citation type="journal article" date="2014" name="J. Biol. Chem." volume="289" first="5518" last="5527">
<title>Deleted in breast cancer 1 (DBC1) protein regulates hepatic gluconeogenesis.</title>
<authorList>
<person name="Nin V."/>
<person name="Chini C.C."/>
<person name="Escande C."/>
<person name="Capellini V."/>
<person name="Chini E.N."/>
</authorList>
<dbReference type="PubMed" id="24415752"/>
<dbReference type="DOI" id="10.1074/jbc.m113.512913"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="95">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-14 AND SER-27</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="96">
<citation type="journal article" date="2014" name="Nat. Commun." volume="5" first="5483" last="5483">
<title>Modification of DBC1 by SUMO2/3 is crucial for p53-mediated apoptosis in response to DNA damage.</title>
<authorList>
<person name="Park J.H."/>
<person name="Lee S.W."/>
<person name="Yang S.W."/>
<person name="Yoo H.M."/>
<person name="Park J.M."/>
<person name="Seong M.W."/>
<person name="Ka S.H."/>
<person name="Oh K.H."/>
<person name="Jeon Y.J."/>
<person name="Chung C.H."/>
</authorList>
<dbReference type="PubMed" id="25406032"/>
<dbReference type="DOI" id="10.1038/ncomms6483"/>
</citation>
<scope>INTERACTION WITH CCAR2 AND TP53</scope>
<scope>MUTAGENESIS OF 256-ILE-ILE-257 AND HIS-363</scope>
<scope>ACTIVE SITE</scope>
</reference>
<reference key="97">
<citation type="journal article" date="2014" name="Nucleic Acids Res." volume="42" first="13150" last="13160">
<title>Chk2 and REGgamma-dependent DBC1 regulation in DNA damage induced apoptosis.</title>
<authorList>
<person name="Magni M."/>
<person name="Ruscica V."/>
<person name="Buscemi G."/>
<person name="Kim J.E."/>
<person name="Nachimuthu B.T."/>
<person name="Fontanella E."/>
<person name="Delia D."/>
<person name="Zannini L."/>
</authorList>
<dbReference type="PubMed" id="25361978"/>
<dbReference type="DOI" id="10.1093/nar/gku1065"/>
</citation>
<scope>INTERACTION WITH CHEK2</scope>
</reference>
<reference key="98">
<citation type="journal article" date="2015" name="Int. J. Cancer" volume="136" first="55" last="64">
<title>MCC inhibits beta-catenin transcriptional activity by sequestering DBC1 in the cytoplasm.</title>
<authorList>
<person name="Pangon L."/>
<person name="Mladenova D."/>
<person name="Watkins L."/>
<person name="Van Kralingen C."/>
<person name="Currey N."/>
<person name="Al-Sohaily S."/>
<person name="Lecine P."/>
<person name="Borg J.P."/>
<person name="Kohonen-Corish M.R."/>
</authorList>
<dbReference type="PubMed" id="24824780"/>
<dbReference type="DOI" id="10.1002/ijc.28967"/>
</citation>
<scope>FUNCTION IN DEACETYLATION OF CTNB1</scope>
</reference>
<reference key="99">
<citation type="journal article" date="2015" name="J. Steroid Biochem. Mol. Biol." volume="149" first="80" last="88">
<title>CCAR2 negatively regulates nuclear receptor LXRalpha by competing with SIRT1 deacetylase.</title>
<authorList>
<person name="Sakurabashi A."/>
<person name="Wada-Hiraike O."/>
<person name="Hirano M."/>
<person name="Fu H."/>
<person name="Isono W."/>
<person name="Fukuda T."/>
<person name="Morita Y."/>
<person name="Tanikawa M."/>
<person name="Miyamoto Y."/>
<person name="Oda K."/>
<person name="Kawana K."/>
<person name="Osuga Y."/>
<person name="Fujii T."/>
</authorList>
<dbReference type="PubMed" id="25661920"/>
<dbReference type="DOI" id="10.1016/j.jsbmb.2015.02.001"/>
</citation>
<scope>INTERACTION WITH NR1H3</scope>
</reference>
<reference key="100">
<citation type="journal article" date="2018" name="Am. J. Hum. Genet." volume="102" first="995" last="1007">
<title>A recurrent de novo PACS2 heterozygous missense variant causes neonatal-onset developmental epileptic encephalopathy, facial dysmorphism, and cerebellar dysgenesis.</title>
<authorList>
<consortium name="DDD Study"/>
<consortium name="C4RCD Research Group"/>
<person name="Olson H.E."/>
<person name="Jean-Marcais N."/>
<person name="Yang E."/>
<person name="Heron D."/>
<person name="Tatton-Brown K."/>
<person name="van der Zwaag P.A."/>
<person name="Bijlsma E.K."/>
<person name="Krock B.L."/>
<person name="Backer E."/>
<person name="Kamsteeg E.J."/>
<person name="Sinnema M."/>
<person name="Reijnders M.R.F."/>
<person name="Bearden D."/>
<person name="Begtrup A."/>
<person name="Telegrafi A."/>
<person name="Lunsing R.J."/>
<person name="Burglen L."/>
<person name="Lesca G."/>
<person name="Cho M.T."/>
<person name="Smith L.A."/>
<person name="Sheidley B.R."/>
<person name="Moufawad El Achkar C."/>
<person name="Pearl P.L."/>
<person name="Poduri A."/>
<person name="Skraban C.M."/>
<person name="Tarpinian J."/>
<person name="Nesbitt A.I."/>
<person name="Fransen van de Putte D.E."/>
<person name="Ruivenkamp C.A.L."/>
<person name="Rump P."/>
<person name="Chatron N."/>
<person name="Sabatier I."/>
<person name="De Bellescize J."/>
<person name="Guibaud L."/>
<person name="Sweetser D.A."/>
<person name="Waxler J.L."/>
<person name="Wierenga K.J."/>
<person name="Donadieu J."/>
<person name="Narayanan V."/>
<person name="Ramsey K.M."/>
<person name="Nava C."/>
<person name="Riviere J.B."/>
<person name="Vitobello A."/>
<person name="Tran Mau-Them F."/>
<person name="Philippe C."/>
<person name="Bruel A.L."/>
<person name="Duffourd Y."/>
<person name="Thomas L."/>
<person name="Lelieveld S.H."/>
<person name="Schuurs-Hoeijmakers J."/>
<person name="Brunner H.G."/>
<person name="Keren B."/>
<person name="Thevenon J."/>
<person name="Faivre L."/>
<person name="Thomas G."/>
<person name="Thauvin-Robinet C."/>
</authorList>
<dbReference type="PubMed" id="29656858"/>
<dbReference type="DOI" id="10.1016/j.ajhg.2018.03.005"/>
</citation>
<scope>INTERACTION WITH PACS2</scope>
</reference>
<reference key="101">
<citation type="journal article" date="2018" name="Mol. Cell" volume="71" first="718" last="732">
<title>Dynamic acetylation of phosphoenolpyruvate carboxykinase toggles enzyme activity between gluconeogenic and anaplerotic reactions.</title>
<authorList>
<person name="Latorre-Muro P."/>
<person name="Baeza J."/>
<person name="Armstrong E.A."/>
<person name="Hurtado-Guerrero R."/>
<person name="Corzana F."/>
<person name="Wu L.E."/>
<person name="Sinclair D.A."/>
<person name="Lopez-Buesa P."/>
<person name="Carrodeguas J.A."/>
<person name="Denu J.M."/>
</authorList>
<dbReference type="PubMed" id="30193097"/>
<dbReference type="DOI" id="10.1016/j.molcel.2018.07.031"/>
</citation>
<scope>FUNCTION IN DEACETYLATION OF PCK1</scope>
</reference>
<reference key="102">
<citation type="journal article" date="2019" name="Cell Rep." volume="29" first="2078" last="2091.e5">
<title>CCDC84 Acetylation Oscillation Regulates Centrosome Duplication by Modulating HsSAS-6 Degradation.</title>
<authorList>
<person name="Wang T."/>
<person name="Zou Y."/>
<person name="Huang N."/>
<person name="Teng J."/>
<person name="Chen J."/>
</authorList>
<dbReference type="PubMed" id="31722219"/>
<dbReference type="DOI" id="10.1016/j.celrep.2019.10.028"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<comment type="function">
<text evidence="18 21 22 24 26 27 28 29 30 31 33 35 36 37 38 39 40 41 42 43 44 46 49 52 54 55 56 59 60 63 64 65 68 69 72 73 74 75 76 77 79 81 82 83 84 85 86 87 88 89 90 93 95 98 99 104 105">NAD-dependent protein deacetylase that links transcriptional regulation directly to intracellular energetics and participates in the coordination of several separated cellular functions such as cell cycle, response to DNA damage, metabolism, apoptosis and autophagy (PubMed:11672523, PubMed:12006491, PubMed:14976264, PubMed:14980222, PubMed:15126506, PubMed:15152190, PubMed:15205477, PubMed:15469825, PubMed:15692560, PubMed:16079181, PubMed:16166628, PubMed:16892051, PubMed:16998810, PubMed:17283066, PubMed:17290224, PubMed:17334224, PubMed:17505061, PubMed:17612497, PubMed:17620057, PubMed:17936707, PubMed:18203716, PubMed:18296641, PubMed:18662546, PubMed:18687677, PubMed:19188449, PubMed:19220062, PubMed:19364925, PubMed:19690166, PubMed:19934257, PubMed:20097625, PubMed:20100829, PubMed:20203304, PubMed:20375098, PubMed:20620956, PubMed:20670893, PubMed:20817729, PubMed:20955178, PubMed:21149730, PubMed:21245319, PubMed:21471201, PubMed:21504832, PubMed:21555002, PubMed:21698133, PubMed:21701047, PubMed:21775285, PubMed:21807113, PubMed:21841822, PubMed:21890893, PubMed:21947282, PubMed:22274616, PubMed:24415752, PubMed:24824780). Can modulate chromatin function through deacetylation of histones and can promote alterations in the methylation of histones and DNA, leading to transcriptional repression (PubMed:15469825). Deacetylates a broad range of transcription factors and coregulators, thereby regulating target gene expression positively and negatively (PubMed:15152190, PubMed:14980222, PubMed:14976264). Serves as a sensor of the cytosolic ratio of NAD(+)/NADH which is altered by glucose deprivation and metabolic changes associated with caloric restriction (PubMed:15205477). Is essential in skeletal muscle cell differentiation and in response to low nutrients mediates the inhibitory effect on skeletal myoblast differentiation which also involves 5'-AMP-activated protein kinase (AMPK) and nicotinamide phosphoribosyltransferase (NAMPT) (By similarity). Component of the eNoSC (energy-dependent nucleolar silencing) complex, a complex that mediates silencing of rDNA in response to intracellular energy status and acts by recruiting histone-modifying enzymes (PubMed:18485871). The eNoSC complex is able to sense the energy status of cell: upon glucose starvation, elevation of NAD(+)/NADP(+) ratio activates SIRT1, leading to histone H3 deacetylation followed by dimethylation of H3 at 'Lys-9' (H3K9me2) by SUV39H1 and the formation of silent chromatin in the rDNA locus (PubMed:18485871, PubMed:21504832). Deacetylates 'Lys-266' of SUV39H1, leading to its activation (PubMed:21504832). Inhibits skeletal muscle differentiation by deacetylating PCAF and MYOD1 (PubMed:19188449). Deacetylates H2A and 'Lys-26' of H1-4 (PubMed:15469825). Deacetylates 'Lys-16' of histone H4 (in vitro). Involved in NR0B2/SHP corepression function through chromatin remodeling: Recruited to LRH1 target gene promoters by NR0B2/SHP thereby stimulating histone H3 and H4 deacetylation leading to transcriptional repression (PubMed:20375098). Proposed to contribute to genomic integrity via positive regulation of telomere length; however, reports on localization to pericentromeric heterochromatin are conflicting (By similarity). Proposed to play a role in constitutive heterochromatin (CH) formation and/or maintenance through regulation of the available pool of nuclear SUV39H1 (PubMed:15469825, PubMed:18004385). Upon oxidative/metabolic stress decreases SUV39H1 degradation by inhibiting SUV39H1 polyubiquitination by MDM2 (PubMed:18004385, PubMed:21504832). This increase in SUV39H1 levels enhances SUV39H1 turnover in CH, which in turn seems to accelerate renewal of the heterochromatin which correlates with greater genomic integrity during stress response (PubMed:18004385, PubMed:21504832). Deacetylates 'Lys-382' of p53/TP53 and impairs its ability to induce transcription-dependent proapoptotic program and modulate cell senescence (PubMed:11672523, PubMed:12006491). Deacetylates TAF1B and thereby represses rDNA transcription by the RNA polymerase I (By similarity). Deacetylates MYC, promotes the association of MYC with MAX and decreases MYC stability leading to compromised transformational capability (PubMed:19364925, PubMed:21807113). Deacetylates FOXO3 in response to oxidative stress thereby increasing its ability to induce cell cycle arrest and resistance to oxidative stress but inhibiting FOXO3-mediated induction of apoptosis transcriptional activity; also leading to FOXO3 ubiquitination and protesomal degradation (PubMed:14980222, PubMed:14976264, PubMed:21841822). Appears to have a similar effect on MLLT7/FOXO4 in regulation of transcriptional activity and apoptosis (PubMed:15126506). Deacetylates DNMT1; thereby impairs DNMT1 methyltransferase-independent transcription repressor activity, modulates DNMT1 cell cycle regulatory function and DNMT1-mediated gene silencing (PubMed:21947282). Deacetylates RELA/NF-kappa-B p65 thereby inhibiting its transactivating potential and augments apoptosis in response to TNF-alpha (PubMed:15152190). Deacetylates HIF1A, KAT5/TIP60, RB1 and HIC1 (PubMed:17620057, PubMed:17283066, PubMed:20100829, PubMed:20620956). Deacetylates FOXO1 resulting in its nuclear retention and enhancement of its transcriptional activity leading to increased gluconeogenesis in liver (PubMed:15692560). Inhibits E2F1 transcriptional activity and apoptotic function, possibly by deacetylation (PubMed:16892051). Involved in HES1- and HEY2-mediated transcriptional repression (PubMed:12535671). In cooperation with MYCN seems to be involved in transcriptional repression of DUSP6/MAPK3 leading to MYCN stabilization by phosphorylation at 'Ser-62' (PubMed:21698133). Deacetylates MEF2D (PubMed:16166628). Required for antagonist-mediated transcription suppression of AR-dependent genes which may be linked to local deacetylation of histone H3 (PubMed:17505061). Represses HNF1A-mediated transcription (By similarity). Required for the repression of ESRRG by CREBZF (PubMed:19690166). Deacetylates NR1H3 and NR1H2 and deacetylation of NR1H3 at 'Lys-434' positively regulates transcription of NR1H3:RXR target genes, promotes NR1H3 proteosomal degradation and results in cholesterol efflux; a promoter clearing mechanism after reach round of transcription is proposed (PubMed:17936707). Involved in lipid metabolism (PubMed:20817729). Implicated in regulation of adipogenesis and fat mobilization in white adipocytes by repression of PPARG which probably involves association with NCOR1 and SMRT/NCOR2 (By similarity). Deacetylates p300/EP300 and PRMT1 (By similarity). Deacetylates ACSS2 leading to its activation, and HMGCS1 deacetylation (PubMed:21701047). Involved in liver and muscle metabolism. Through deacetylation and activation of PPARGC1A is required to activate fatty acid oxidation in skeletal muscle under low-glucose conditions and is involved in glucose homeostasis. Involved in regulation of PPARA and fatty acid beta-oxidation in liver. Involved in positive regulation of insulin secretion in pancreatic beta cells in response to glucose; the function seems to imply transcriptional repression of UCP2. Proposed to deacetylate IRS2 thereby facilitating its insulin-induced tyrosine phosphorylation. Deacetylates SREBF1 isoform SREBP-1C thereby decreasing its stability and transactivation in lipogenic gene expression (PubMed:17290224, PubMed:20817729). Involved in DNA damage response by repressing genes which are involved in DNA repair, such as XPC and TP73, deacetylating XRCC6/Ku70, and facilitating recruitment of additional factors to sites of damaged DNA, such as SIRT1-deacetylated NBN can recruit ATM to initiate DNA repair and SIRT1-deacetylated XPA interacts with RPA2 (PubMed:15205477, PubMed:17334224, PubMed:16998810, PubMed:17612497, PubMed:20670893, PubMed:21149730). Also involved in DNA repair of DNA double-strand breaks by homologous recombination and specifically single-strand annealing independently of XRCC6/Ku70 and NBN (PubMed:15205477, PubMed:17334224, PubMed:20097625). Transcriptional suppression of XPC probably involves an E2F4:RBL2 suppressor complex and protein kinase B (AKT) signaling. Transcriptional suppression of TP73 probably involves E2F4 and PCAF. Deacetylates WRN thereby regulating its helicase and exonuclease activities and regulates WRN nuclear translocation in response to DNA damage (PubMed:18203716). Deacetylates APEX1 at 'Lys-6' and 'Lys-7' and stimulates cellular AP endonuclease activity by promoting the association of APEX1 to XRCC1 (PubMed:19934257). Increases p53/TP53-mediated transcription-independent apoptosis by blocking nuclear translocation of cytoplasmic p53/TP53 and probably redirecting it to mitochondria. Deacetylates XRCC6/Ku70 at 'Lys-539' and 'Lys-542' causing it to sequester BAX away from mitochondria thereby inhibiting stress-induced apoptosis. Is involved in autophagy, presumably by deacetylating ATG5, ATG7 and MAP1LC3B/ATG8 (PubMed:18296641). Deacetylates AKT1 which leads to enhanced binding of AKT1 and PDK1 to PIP3 and promotes their activation (PubMed:21775285). Proposed to play role in regulation of STK11/LBK1-dependent AMPK signaling pathways implicated in cellular senescence which seems to involve the regulation of the acetylation status of STK11/LBK1. Can deacetylate STK11/LBK1 and thereby increase its activity, cytoplasmic localization and association with STRAD; however, the relevance of such activity in normal cells is unclear (PubMed:18687677, PubMed:20203304). In endothelial cells is shown to inhibit STK11/LBK1 activity and to promote its degradation. Deacetylates SMAD7 at 'Lys-64' and 'Lys-70' thereby promoting its degradation. Deacetylates CIITA and augments its MHC class II transactivation and contributes to its stability (PubMed:21890893). Deacetylates MECOM/EVI1 (PubMed:21555002). Deacetylates PML at 'Lys-487' and this deacetylation promotes PML control of PER2 nuclear localization (PubMed:22274616). During the neurogenic transition, represses selective NOTCH1-target genes through histone deacetylation in a BCL6-dependent manner and leading to neuronal differentiation. Regulates the circadian expression of several core clock genes, including ARNTL/BMAL1, RORC, PER2 and CRY1 and plays a critical role in maintaining a controlled rhythmicity in histone acetylation, thereby contributing to circadian chromatin remodeling (PubMed:18662546). Deacetylates ARNTL/BMAL1 and histones at the circadian gene promoters in order to facilitate repression by inhibitory components of the circadian oscillator (By similarity). Deacetylates PER2, facilitating its ubiquitination and degradation by the proteosome (By similarity). Protects cardiomyocytes against palmitate-induced apoptosis (By similarity). Deacetylates XBP1 isoform 2; deacetylation decreases protein stability of XBP1 isoform 2 and inhibits its transcriptional activity (PubMed:20955178). Deacetylates PCK1 and directs its activity toward phosphoenolpyruvate production promoting gluconeogenesis (PubMed:30193097). Involved in the CCAR2-mediated regulation of PCK1 and NR1D1 (PubMed:24415752). Deacetylates CTNB1 at 'Lys-49' (PubMed:24824780). In POMC (pro-opiomelanocortin) neurons, required for leptin-induced activation of PI3K signaling (By similarity). In addition to protein deacetylase activity, also acts as protein-lysine deacylase: acts as a protein depropionylase by mediating depropionylation of Osterix (SP7) (By similarity). Deacetylates SOX9; promoting SOX9 nuclear localization and transactivation activity (By similarity). Involved in the regulation of centrosome duplication. Deacetylates CENATAC in G1 phase, allowing for SASS6 accumulation on the centrosome and subsequent procentriole assembly (PubMed:31722219).</text>
</comment>
<comment type="function">
<molecule>Isoform 2</molecule>
<text evidence="78">Deacetylates 'Lys-382' of p53/TP53, however with lower activity than isoform 1. In combination, the two isoforms exert an additive effect. Isoform 2 regulates p53/TP53 expression and cellular stress response and is in turn repressed by p53/TP53 presenting a SIRT1 isoform-dependent auto-regulatory loop.</text>
</comment>
<comment type="function">
<text evidence="53">(Microbial infection) In case of HIV-1 infection, interacts with and deacetylates the viral Tat protein. The viral Tat protein inhibits SIRT1 deacetylation activity toward RELA/NF-kappa-B p65, thereby potentiates its transcriptional activity and SIRT1 is proposed to contribute to T-cell hyperactivation during infection.</text>
</comment>
<comment type="function">
<molecule>SirtT1 75 kDa fragment</molecule>
<text evidence="94">Catalytically inactive 75SirT1 may be involved in regulation of apoptosis. May be involved in protecting chondrocytes from apoptotic death by associating with cytochrome C and interfering with apoptosome assembly.</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="19 22">
<text>H2O + N(6)-acetyl-L-lysyl-[protein] + NAD(+) = 2''-O-acetyl-ADP-D-ribose + L-lysyl-[protein] + nicotinamide</text>
<dbReference type="Rhea" id="RHEA:43636"/>
<dbReference type="Rhea" id="RHEA-COMP:9752"/>
<dbReference type="Rhea" id="RHEA-COMP:10731"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:17154"/>
<dbReference type="ChEBI" id="CHEBI:29969"/>
<dbReference type="ChEBI" id="CHEBI:57540"/>
<dbReference type="ChEBI" id="CHEBI:61930"/>
<dbReference type="ChEBI" id="CHEBI:83767"/>
<dbReference type="EC" id="2.3.1.286"/>
</reaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="18">
<text>H2O + N(6)-propanoyl-L-lysyl-[protein] + NAD(+) = 3''-O-propanoyl-ADP-D-ribose + L-lysyl-[protein] + nicotinamide</text>
<dbReference type="Rhea" id="RHEA:23500"/>
<dbReference type="Rhea" id="RHEA-COMP:9752"/>
<dbReference type="Rhea" id="RHEA-COMP:13758"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:17154"/>
<dbReference type="ChEBI" id="CHEBI:29969"/>
<dbReference type="ChEBI" id="CHEBI:57540"/>
<dbReference type="ChEBI" id="CHEBI:138019"/>
<dbReference type="ChEBI" id="CHEBI:145015"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="18">
<dbReference type="Rhea" id="RHEA:23501"/>
</physiologicalReaction>
</comment>
<comment type="cofactor">
<cofactor evidence="17">
<name>Zn(2+)</name>
<dbReference type="ChEBI" id="CHEBI:29105"/>
</cofactor>
<text evidence="17">Binds 1 zinc ion per subunit.</text>
</comment>
<comment type="activity regulation">
<text evidence="23 25 50 51">Inhibited by nicotinamide. Activated by resveratrol (3,5,4'-trihydroxy-trans-stilbene), butein (3,4,2',4'-tetrahydroxychalcone), piceatannol (3,5,3',4'-tetrahydroxy-trans-stilbene), Isoliquiritigenin (4,2',4'-trihydroxychalcone), fisetin (3,7,3',4'-tetrahydroxyflavone) and quercetin (3,5,7,3',4'-pentahydroxyflavone). MAPK8/JNK1 and RPS19BP1/AROS act as positive regulators of deacetylation activity. Negatively regulated by CCAR2.</text>
</comment>
<comment type="subunit">
<text evidence="18 22 24 32 33 36 37 45 47 50 51 54 62 64 67 71 73 77 78 81 85 91 92 96 97 100 101 102 103">Interacts with XBP1 isoform 2 (PubMed:20955178). Found in a complex with PCAF and MYOD1. Interacts with FOXO1; the interaction deacetylates FOXO1, resulting in its nuclear retention and promotion of its transcriptional activity Component of the eNoSC complex, composed of SIRT1, SUV39H1 and RRP8. Interacts with HES1, HEY2 and PML. Interacts with RPS19BP1/AROS. Interacts with CCAR2 (via N-terminus); the interaction disrupts the interaction between SIRT1 and p53/TP53. Interacts with SETD7; the interaction induces the dissociation of SIRT1 from p53/TP53 and increases p53/TP53 activity. Interacts with MYCN, NR1I2, CREBZF, TSC2, TLE1, FOS, JUN, NR0B2, PPARG, NCOR, IRS1, IRS2 and NMNAT1. Interacts with HNF1A; the interaction occurs under nutrient restriction. Interacts with SUZ12; the interaction mediates the association with the PRC4 histone methylation complex which is specific as an association with PCR2 and PCR3 complex variants is not found. Interacts with BCL6; leads to a epigenetic repression of specific target genes. Interacts with CLOCK, ARNTL/BMAL1 and PER2 (By similarity). Interacts with PPARA; the interaction seems to be modulated by NAD(+) levels (PubMed:24043310). Interacts with NR1H3 and this interaction is inhibited in the presence of CCAR2. Interacts with CHEK2. Interacts with p53/TP53. Exhibits a preferential interaction with sumoylated CCAR2 over its unmodified form. Interacts with PACS2 (PubMed:29656858). Interacts with SIRT7 (By similarity).</text>
</comment>
<comment type="subunit">
<text evidence="34 53">(Microbial infection) Interacts with HIV-1 Tat.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1802965">
<id>Q96EB6</id>
</interactant>
<interactant intactId="EBI-717681">
<id>Q13085</id>
<label>ACACA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1802965">
<id>Q96EB6</id>
</interactant>
<interactant intactId="EBI-296087">
<id>P31749</id>
<label>AKT1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1802965">
<id>Q96EB6</id>
</interactant>
<interactant intactId="EBI-1048805">
<id>P27695</id>
<label>APEX1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1802965">
<id>Q96EB6</id>
</interactant>
<interactant intactId="EBI-987834">
<id>O95352</id>
<label>ATG7</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1802965">
<id>Q96EB6</id>
</interactant>
<interactant intactId="EBI-355410">
<id>Q8N163</id>
<label>CCAR2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>16</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1802965">
<id>Q96EB6</id>
</interactant>
<interactant intactId="EBI-1538819">
<id>P33076</id>
<label>CIITA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1802965">
<id>Q96EB6</id>
</interactant>
<interactant intactId="EBI-632965">
<id>Q9NS37</id>
<label>CREBZF</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1802965">
<id>Q96EB6</id>
</interactant>
<interactant intactId="EBI-347804">
<id>P68400</id>
<label>CSNK2A1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1802965">
<id>Q96EB6</id>
</interactant>
<interactant intactId="EBI-348169">
<id>P67870</id>
<label>CSNK2B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1802965">
<id>Q96EB6</id>
</interactant>
<interactant intactId="EBI-719459">
<id>P26358</id>
<label>DNMT1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>11</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1802965">
<id>Q96EB6</id>
</interactant>
<interactant intactId="EBI-723489">
<id>O14640</id>
<label>DVL1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1802965">
<id>Q96EB6</id>
</interactant>
<interactant intactId="EBI-739789">
<id>Q92997</id>
<label>DVL3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1802965">
<id>Q96EB6</id>
</interactant>
<interactant intactId="EBI-448924">
<id>Q01094</id>
<label>E2F1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1802965">
<id>Q96EB6</id>
</interactant>
<interactant intactId="EBI-447295">
<id>Q09472</id>
<label>EP300</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1802965">
<id>Q96EB6</id>
</interactant>
<interactant intactId="EBI-701903">
<id>Q14192</id>
<label>FHL2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1802965">
<id>Q96EB6</id>
</interactant>
<interactant intactId="EBI-1108782">
<id>Q12778</id>
<label>FOXO1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1802965">
<id>Q96EB6</id>
</interactant>
<interactant intactId="EBI-1644164">
<id>O43524</id>
<label>FOXO3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1802965">
<id>Q96EB6</id>
</interactant>
<interactant intactId="EBI-4481939">
<id>P98177</id>
<label>FOXO4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1802965">
<id>Q96EB6</id>
</interactant>
<interactant intactId="EBI-396176">
<id>P51610</id>
<label>HCFC1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1802965">
<id>Q96EB6</id>
</interactant>
<interactant intactId="EBI-2832522">
<id>Q14469</id>
<label>HES1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1802965">
<id>Q96EB6</id>
</interactant>
<interactant intactId="EBI-750630">
<id>Q9UBP5</id>
<label>HEY2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1802965">
<id>Q96EB6</id>
</interactant>
<interactant intactId="EBI-1049582">
<id>Q9Y4H2</id>
<label>IRS2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1802965">
<id>Q96EB6</id>
</interactant>
<interactant intactId="EBI-477430">
<id>Q92831</id>
<label>KAT2B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1802965">
<id>Q96EB6</id>
</interactant>
<interactant intactId="EBI-591370">
<id>Q03164</id>
<label>KMT2A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1802965">
<id>Q96EB6</id>
</interactant>
<interactant intactId="EBI-373144">
<id>Q9GZQ8</id>
<label>MAP1LC3B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1802965">
<id>Q96EB6</id>
</interactant>
<interactant intactId="EBI-1384862">
<id>Q03112</id>
<label>MECOM</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1802965">
<id>Q96EB6</id>
</interactant>
<interactant intactId="EBI-359260">
<id>P42345</id>
<label>MTOR</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1802965">
<id>Q96EB6</id>
</interactant>
<interactant intactId="EBI-447544">
<id>P01106</id>
<label>MYC</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1802965">
<id>Q96EB6</id>
</interactant>
<interactant intactId="EBI-878369">
<id>P04198</id>
<label>MYCN</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1802965">
<id>Q96EB6</id>
</interactant>
<interactant intactId="EBI-494844">
<id>O60934</id>
<label>NBN</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1802965">
<id>Q96EB6</id>
</interactant>
<interactant intactId="EBI-5378683">
<id>Q02577</id>
<label>NHLH2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1802965">
<id>Q96EB6</id>
</interactant>
<interactant intactId="EBI-3917542">
<id>Q9HAN9</id>
<label>NMNAT1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1802965">
<id>Q96EB6</id>
</interactant>
<interactant intactId="EBI-3910729">
<id>Q15466</id>
<label>NR0B2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1802965">
<id>Q96EB6</id>
</interactant>
<interactant intactId="EBI-79464">
<id>P27986</id>
<label>PIK3R1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1802965">
<id>Q96EB6</id>
</interactant>
<interactant intactId="EBI-781384">
<id>P37231</id>
<label>PPARG</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1802965">
<id>Q96EB6</id>
</interactant>
<interactant intactId="EBI-413374">
<id>P10276</id>
<label>RARA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1802965">
<id>Q96EB6</id>
</interactant>
<interactant intactId="EBI-73886">
<id>Q04206</id>
<label>RELA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1802965">
<id>Q96EB6</id>
</interactant>
<interactant intactId="EBI-4479407">
<id>Q86WX3</id>
<label>RPS19BP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>11</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1802965">
<id>Q96EB6</id>
</interactant>
<interactant intactId="EBI-1567928">
<id>Q8N122</id>
<label>RPTOR</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1802965">
<id>Q96EB6</id>
</interactant>
<interactant intactId="EBI-2008793">
<id>O43159</id>
<label>RRP8</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1802965">
<id>Q96EB6</id>
</interactant>
<interactant intactId="EBI-1268586">
<id>Q8WTS6</id>
<label>SETD7</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>11</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1802965">
<id>Q96EB6</id>
</interactant>
<interactant intactId="EBI-632715">
<id>Q13573</id>
<label>SNW1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1802965">
<id>Q96EB6</id>
</interactant>
<interactant intactId="EBI-948338">
<id>P36956-3</id>
<label>SREBF1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1802965">
<id>Q96EB6</id>
</interactant>
<interactant intactId="EBI-349968">
<id>O43463</id>
<label>SUV39H1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1802965">
<id>Q96EB6</id>
</interactant>
<interactant intactId="EBI-711424">
<id>Q04724</id>
<label>TLE1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1802965">
<id>Q96EB6</id>
</interactant>
<interactant intactId="EBI-366083">
<id>P04637</id>
<label>TP53</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>18</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1802965">
<id>Q96EB6</id>
</interactant>
<interactant intactId="EBI-389606">
<id>O15350</id>
<label>TP73</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1802965">
<id>Q96EB6</id>
</interactant>
<interactant intactId="EBI-396587">
<id>P49815</id>
<label>TSC2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1802965">
<id>Q96EB6</id>
</interactant>
<interactant intactId="EBI-368417">
<id>Q14191</id>
<label>WRN</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>9</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1802965">
<id>Q96EB6</id>
</interactant>
<interactant intactId="EBI-295222">
<id>P23025</id>
<label>XPA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1802965">
<id>Q96EB6</id>
</interactant>
<interactant intactId="EBI-353208">
<id>P12956</id>
<label>XRCC6</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1802965">
<id>Q96EB6</id>
</interactant>
<interactant intactId="EBI-1371343">
<id>Q9R1E0</id>
<label>Foxo1</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1802965">
<id>Q96EB6</id>
</interactant>
<interactant intactId="EBI-349004">
<id>Q60974</id>
<label>Ncor1</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1802965">
<id>Q96EB6</id>
</interactant>
<interactant intactId="EBI-5276809">
<id>Q60644</id>
<label>Nr1h2</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1802965">
<id>Q96EB6</id>
</interactant>
<interactant intactId="EBI-5276764">
<id>Q9Z0Y9</id>
<label>Nr1h3</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1802965">
<id>Q96EB6</id>
</interactant>
<interactant intactId="EBI-5260705">
<id>P37238</id>
<label>Pparg</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1802965">
<id>Q96EB6</id>
</interactant>
<interactant intactId="EBI-6267861">
<id>P37238-1</id>
<label>Pparg</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1802965">
<id>Q96EB6</id>
</interactant>
<interactant intactId="EBI-6164389">
<id>P04608</id>
<label>tat</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="22">Nucleus</location>
<location evidence="22">PML body</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="66">Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="21 31 35 65 66 70 77">Nucleus</location>
</subcellularLocation>
<text evidence="18 22 31 65 77">Recruited to the nuclear bodies via its interaction with PML (PubMed:12006491). Colocalized with APEX1 in the nucleus (PubMed:19934257). May be found in nucleolus, nuclear euchromatin, heterochromatin and inner membrane (PubMed:15469825). Shuttles between nucleus and cytoplasm (By similarity). Colocalizes in the nucleus with XBP1 isoform 2 (PubMed:20955178).</text>
</comment>
<comment type="subcellular location">
<molecule>SirtT1 75 kDa fragment</molecule>
<subcellularLocation>
<location evidence="94">Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="94">Mitochondrion</location>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q96EB6-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q96EB6-2</id>
<name>2</name>
<name>delta-exon8</name>
<sequence type="described" ref="VSP_042189"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="20">Widely expressed.</text>
</comment>
<comment type="induction">
<text evidence="30 65">Up-regulated by methyl methanesulfonate (MMS). In H293T cells by presence of rat calorie restriction (CR) serum.</text>
</comment>
<comment type="PTM">
<text evidence="81">Methylated on multiple lysine residues; methylation is enhanced after DNA damage and is dispensable for deacetylase activity toward p53/TP53.</text>
</comment>
<comment type="PTM">
<text evidence="18 57 58 61 66 80 82">Phosphorylated. Phosphorylated by STK4/MST1, resulting in inhibition of SIRT1-mediated p53/TP53 deacetylation. Phosphorylation by MAPK8/JNK1 at Ser-27, Ser-47, and Thr-530 leads to increased nuclear localization and enzymatic activity. Phosphorylation at Thr-530 by DYRK1A and DYRK3 activates deacetylase activity and promotes cell survival. Phosphorylation by mammalian target of rapamycin complex 1 (mTORC1) at Ser-47 inhibits deacetylation activity. Phosphorylated by CaMK2, leading to increased p53/TP53 and NF-kappa-B p65/RELA deacetylation activity (By similarity). Phosphorylation at Ser-27 implicating MAPK9 is linked to protein stability. There is some ambiguity for some phosphosites: Ser-159/Ser-162 and Thr-544/Ser-545.</text>
</comment>
<comment type="PTM">
<text evidence="94">Proteolytically cleaved by cathepsin B upon TNF-alpha treatment to yield catalytic inactive but stable SirtT1 75 kDa fragment (75SirT1).</text>
</comment>
<comment type="PTM">
<text evidence="18">S-nitrosylated by GAPDH, leading to inhibit the NAD-dependent protein deacetylase activity.</text>
</comment>
<comment type="PTM">
<text evidence="18">Acetylated at various Lys residues. Deacetylated via an autocatalytic mechanism. Autodeacetylation at Lys-238 promotes its protein deacetylase activity.</text>
</comment>
<comment type="miscellaneous">
<text>Red wine, which contains resveratrol, may participate in activation of sirtuin proteins, and may therefore participate in an extended lifespan as it has been observed in yeast.</text>
</comment>
<comment type="miscellaneous">
<text evidence="108">Calf histone H1 is used as substrate in the in vitro deacetylation assay (PubMed:15469825). As, in vivo, interaction occurs between SIRT1 with H1-4, deacetylation has been validated only for H1-4.</text>
</comment>
<comment type="miscellaneous">
<text evidence="110">The reported ADP-ribosyltransferase activity of sirtuins is likely some inefficient side reaction of the deacetylase activity and may not be physiologically relevant.</text>
</comment>
<comment type="similarity">
<text evidence="107">Belongs to the sirtuin family. Class I subfamily.</text>
</comment>
<comment type="sequence caution" evidence="107">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="AAH12499" version="1"/>
</conflict>
<text>Truncated N-terminus.</text>
</comment>
<comment type="online information" name="NIEHS-SNPs">
<link uri="http://egp.gs.washington.edu/data/sirt1/"/>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/SIRT1ID44006ch10q21.html"/>
</comment>
<dbReference type="EC" id="2.3.1.286" evidence="22"/>
<dbReference type="EC" id="2.3.1.-" evidence="18"/>
<dbReference type="EMBL" id="AF083106">
<property type="protein sequence ID" value="AAD40849.2"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF235040">
<property type="protein sequence ID" value="AAG38486.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="DQ278604">
<property type="protein sequence ID" value="ABB72675.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL133551">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC012499">
<property type="protein sequence ID" value="AAH12499.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS7273.1">
<molecule id="Q96EB6-1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001135970.1">
<property type="nucleotide sequence ID" value="NM_001142498.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001300978.1">
<property type="nucleotide sequence ID" value="NM_001314049.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_036370.2">
<molecule id="Q96EB6-1"/>
<property type="nucleotide sequence ID" value="NM_012238.4"/>
</dbReference>
<dbReference type="PDB" id="4I5I">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A/B=241-516"/>
</dbReference>
<dbReference type="PDB" id="4IF6">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.25"/>
<property type="chains" value="A=234-510, B=641-665"/>
</dbReference>
<dbReference type="PDB" id="4IG9">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.64"/>
<property type="chains" value="A/C/E/G=234-510, B/D/F/H=641-665"/>
</dbReference>
<dbReference type="PDB" id="4KXQ">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.85"/>
<property type="chains" value="A=234-510, B=641-663"/>
</dbReference>
<dbReference type="PDB" id="4ZZH">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.10"/>
<property type="chains" value="A=183-505"/>
</dbReference>
<dbReference type="PDB" id="4ZZI">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.73"/>
<property type="chains" value="A=183-505"/>
</dbReference>
<dbReference type="PDB" id="4ZZJ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.74"/>
<property type="chains" value="A=183-505"/>
</dbReference>
<dbReference type="PDB" id="5BTR">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.20"/>
<property type="chains" value="A/B/C=143-665"/>
</dbReference>
<dbReference type="PDBsum" id="4I5I"/>
<dbReference type="PDBsum" id="4IF6"/>
<dbReference type="PDBsum" id="4IG9"/>
<dbReference type="PDBsum" id="4KXQ"/>
<dbReference type="PDBsum" id="4ZZH"/>
<dbReference type="PDBsum" id="4ZZI"/>
<dbReference type="PDBsum" id="4ZZJ"/>
<dbReference type="PDBsum" id="5BTR"/>
<dbReference type="SMR" id="Q96EB6"/>
<dbReference type="BioGRID" id="116983">
<property type="interactions" value="283"/>
</dbReference>
<dbReference type="ComplexPortal" id="CPX-467">
<property type="entry name" value="eNoSc complex"/>
</dbReference>
<dbReference type="CORUM" id="Q96EB6"/>
<dbReference type="DIP" id="DIP-29757N"/>
<dbReference type="IntAct" id="Q96EB6">
<property type="interactions" value="173"/>
</dbReference>
<dbReference type="MINT" id="Q96EB6"/>
<dbReference type="STRING" id="9606.ENSP00000212015"/>
<dbReference type="BindingDB" id="Q96EB6"/>
<dbReference type="ChEMBL" id="CHEMBL4506"/>
<dbReference type="DrugBank" id="DB15493">
<property type="generic name" value="Cambinol"/>
</dbReference>
<dbReference type="DrugBank" id="DB02709">
<property type="generic name" value="Resveratrol"/>
</dbReference>
<dbReference type="DrugBank" id="DB13978">
<property type="generic name" value="Selisistat"/>
</dbReference>
<dbReference type="DrugCentral" id="Q96EB6"/>
<dbReference type="GuidetoPHARMACOLOGY" id="2707"/>
<dbReference type="iPTMnet" id="Q96EB6"/>
<dbReference type="MetOSite" id="Q96EB6"/>
<dbReference type="PhosphoSitePlus" id="Q96EB6"/>
<dbReference type="BioMuta" id="SIRT1"/>
<dbReference type="DMDM" id="38258633"/>
<dbReference type="EPD" id="Q96EB6"/>
<dbReference type="jPOST" id="Q96EB6"/>
<dbReference type="MassIVE" id="Q96EB6"/>
<dbReference type="MaxQB" id="Q96EB6"/>
<dbReference type="PaxDb" id="Q96EB6"/>
<dbReference type="PeptideAtlas" id="Q96EB6"/>
<dbReference type="PRIDE" id="Q96EB6"/>
<dbReference type="ProteomicsDB" id="76393">
<molecule id="Q96EB6-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="76394">
<molecule id="Q96EB6-2"/>
</dbReference>
<dbReference type="Antibodypedia" id="1637">
<property type="antibodies" value="1095 antibodies"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000212015">
<molecule id="Q96EB6-1"/>
<property type="protein sequence ID" value="ENSP00000212015"/>
<property type="gene ID" value="ENSG00000096717"/>
</dbReference>
<dbReference type="GeneID" id="23411"/>
<dbReference type="KEGG" id="hsa:23411"/>
<dbReference type="UCSC" id="uc001jnd.3">
<molecule id="Q96EB6-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="23411"/>
<dbReference type="DisGeNET" id="23411"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000096717.11"/>
<dbReference type="GeneCards" id="SIRT1"/>
<dbReference type="HGNC" id="HGNC:14929">
<property type="gene designation" value="SIRT1"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000096717">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MIM" id="604479">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q96EB6"/>
<dbReference type="OpenTargets" id="ENSG00000096717"/>
<dbReference type="PharmGKB" id="PA37935"/>
<dbReference type="eggNOG" id="KOG2684">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000159406"/>
<dbReference type="HOGENOM" id="CLU_016587_0_0_1"/>
<dbReference type="InParanoid" id="Q96EB6"/>
<dbReference type="KO" id="K11411"/>
<dbReference type="OMA" id="CVEEKSQ"/>
<dbReference type="OrthoDB" id="751525at2759"/>
<dbReference type="PhylomeDB" id="Q96EB6"/>
<dbReference type="TreeFam" id="TF105896"/>
<dbReference type="PathwayCommons" id="Q96EB6"/>
<dbReference type="Reactome" id="R-HSA-3371453">
<property type="pathway name" value="Regulation of HSF1-mediated heat shock response"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-400253">
<property type="pathway name" value="Circadian Clock"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-427359">
<property type="pathway name" value="SIRT1 negatively regulates rRNA expression"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9617629">
<property type="pathway name" value="Regulation of FOXO transcriptional activity by acetylation"/>
</dbReference>
<dbReference type="SABIO-RK" id="Q96EB6"/>
<dbReference type="SignaLink" id="Q96EB6"/>
<dbReference type="SIGNOR" id="Q96EB6"/>
<dbReference type="BioGRID-ORCS" id="23411">
<property type="hits" value="6 hits in 877 CRISPR screens"/>
</dbReference>
<dbReference type="GeneWiki" id="Sirtuin_1"/>
<dbReference type="GenomeRNAi" id="23411"/>
<dbReference type="Pharos" id="Q96EB6">
<property type="development level" value="Tchem"/>
</dbReference>
<dbReference type="PRO" id="PR:Q96EB6"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 10"/>
</dbReference>
<dbReference type="RNAct" id="Q96EB6">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000096717">
<property type="expression patterns" value="Expressed in testis and 227 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q96EB6">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q96EB6">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005677">
<property type="term" value="C:chromatin silencing complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005739">
<property type="term" value="C:mitochondrion"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0000790">
<property type="term" value="C:nuclear chromatin"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005635">
<property type="term" value="C:nuclear envelope"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005719">
<property type="term" value="C:nuclear euchromatin"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005720">
<property type="term" value="C:nuclear heterochromatin"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005637">
<property type="term" value="C:nuclear inner membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005730">
<property type="term" value="C:nucleolus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016605">
<property type="term" value="C:PML body"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0033553">
<property type="term" value="C:rDNA heterochromatin"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043425">
<property type="term" value="F:bHLH transcription factor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019213">
<property type="term" value="F:deacetylase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019899">
<property type="term" value="F:enzyme binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042393">
<property type="term" value="F:histone binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004407">
<property type="term" value="F:histone deacetylase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043398">
<property type="term" value="F:HLH domain binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1990254">
<property type="term" value="F:keratin filament binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046872">
<property type="term" value="F:metal ion binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0051019">
<property type="term" value="F:mitogen-activated protein kinase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0070403">
<property type="term" value="F:NAD+ binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0017136">
<property type="term" value="F:NAD-dependent histone deacetylase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0046969">
<property type="term" value="F:NAD-dependent histone deacetylase activity (H3-K9 specific)"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0034979">
<property type="term" value="F:NAD-dependent protein deacetylase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035257">
<property type="term" value="F:nuclear hormone receptor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0002039">
<property type="term" value="F:p53 binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0008022">
<property type="term" value="F:protein C-terminus binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0033558">
<property type="term" value="F:protein deacetylase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0106231">
<property type="term" value="F:protein-propionyllysine depropionylase activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000978">
<property type="term" value="F:RNA polymerase II cis-regulatory region sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0003713">
<property type="term" value="F:transcription coactivator activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0003714">
<property type="term" value="F:transcription corepressor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0008134">
<property type="term" value="F:transcription factor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001525">
<property type="term" value="P:angiogenesis"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042595">
<property type="term" value="P:behavioral response to starvation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007569">
<property type="term" value="P:cell aging"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0001678">
<property type="term" value="P:cellular glucose homeostasis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006974">
<property type="term" value="P:cellular response to DNA damage stimulus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070301">
<property type="term" value="P:cellular response to hydrogen peroxide"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0071456">
<property type="term" value="P:cellular response to hypoxia"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071479">
<property type="term" value="P:cellular response to ionizing radiation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1990830">
<property type="term" value="P:cellular response to leukemia inhibitory factor"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0009267">
<property type="term" value="P:cellular response to starvation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0071356">
<property type="term" value="P:cellular response to tumor necrosis factor"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035356">
<property type="term" value="P:cellular triglyceride homeostasis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042632">
<property type="term" value="P:cholesterol homeostasis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006325">
<property type="term" value="P:chromatin organization"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032922">
<property type="term" value="P:circadian regulation of gene expression"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006346">
<property type="term" value="P:DNA methylation-dependent heterochromatin assembly"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000731">
<property type="term" value="P:DNA synthesis involved in DNA repair"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0055089">
<property type="term" value="P:fatty acid homeostasis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031507">
<property type="term" value="P:heterochromatin assembly"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0070829">
<property type="term" value="P:heterochromatin maintenance"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0016575">
<property type="term" value="P:histone deacetylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070932">
<property type="term" value="P:histone H3 deacetylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042771">
<property type="term" value="P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0033210">
<property type="term" value="P:leptin-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010934">
<property type="term" value="P:macrophage cytokine production"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030225">
<property type="term" value="P:macrophage differentiation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007517">
<property type="term" value="P:muscle organ development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0060766">
<property type="term" value="P:negative regulation of androgen receptor signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043066">
<property type="term" value="P:negative regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000480">
<property type="term" value="P:negative regulation of cAMP-dependent protein kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030308">
<property type="term" value="P:negative regulation of cell growth"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:2000655">
<property type="term" value="P:negative regulation of cellular response to testosterone stimulus"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:2000773">
<property type="term" value="P:negative regulation of cellular senescence"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043518">
<property type="term" value="P:negative regulation of DNA damage response, signal transduction by p53 class mediator"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043433">
<property type="term" value="P:negative regulation of DNA-binding transcription factor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045599">
<property type="term" value="P:negative regulation of fat cell differentiation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0010629">
<property type="term" value="P:negative regulation of gene expression"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="AgBase"/>
</dbReference>
<dbReference type="GO" id="GO:0051097">
<property type="term" value="P:negative regulation of helicase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071441">
<property type="term" value="P:negative regulation of histone H3-K14 acetylation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CACAO"/>
</dbReference>
<dbReference type="GO" id="GO:1900113">
<property type="term" value="P:negative regulation of histone H3-K9 trimethylation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:2000619">
<property type="term" value="P:negative regulation of histone H4-K16 acetylation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CACAO"/>
</dbReference>
<dbReference type="GO" id="GO:0043124">
<property type="term" value="P:negative regulation of I-kappaB kinase/NF-kappaB signaling"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1902166">
<property type="term" value="P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1901215">
<property type="term" value="P:negative regulation of neuron death"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032088">
<property type="term" value="P:negative regulation of NF-kappaB transcription factor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1902176">
<property type="term" value="P:negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:2000757">
<property type="term" value="P:negative regulation of peptidyl-lysine acetylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042326">
<property type="term" value="P:negative regulation of phosphorylation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031393">
<property type="term" value="P:negative regulation of prostaglandin biosynthetic process"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1901984">
<property type="term" value="P:negative regulation of protein acetylation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="AgBase"/>
</dbReference>
<dbReference type="GO" id="GO:0051898">
<property type="term" value="P:negative regulation of protein kinase B signaling"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032007">
<property type="term" value="P:negative regulation of TOR signaling"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000122">
<property type="term" value="P:negative regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045892">
<property type="term" value="P:negative regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030512">
<property type="term" value="P:negative regulation of transforming growth factor beta receptor signaling pathway"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001542">
<property type="term" value="P:ovulation from ovarian follicle"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0018394">
<property type="term" value="P:peptidyl-lysine acetylation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0034983">
<property type="term" value="P:peptidyl-lysine deacetylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0002821">
<property type="term" value="P:positive regulation of adaptive immune response"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1904179">
<property type="term" value="P:positive regulation of adipose tissue development"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045766">
<property type="term" value="P:positive regulation of angiogenesis"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043065">
<property type="term" value="P:positive regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043536">
<property type="term" value="P:positive regulation of blood vessel endothelial cell migration"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:2000481">
<property type="term" value="P:positive regulation of cAMP-dependent protein kinase activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008284">
<property type="term" value="P:positive regulation of cell population proliferation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000774">
<property type="term" value="P:positive regulation of cellular senescence"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010875">
<property type="term" value="P:positive regulation of cholesterol efflux"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043280">
<property type="term" value="P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045739">
<property type="term" value="P:positive regulation of DNA repair"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1902237">
<property type="term" value="P:positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001938">
<property type="term" value="P:positive regulation of endothelial cell proliferation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="AgBase"/>
</dbReference>
<dbReference type="GO" id="GO:0045722">
<property type="term" value="P:positive regulation of gluconeogenesis"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051574">
<property type="term" value="P:positive regulation of histone H3-K9 methylation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046628">
<property type="term" value="P:positive regulation of insulin receptor signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016239">
<property type="term" value="P:positive regulation of macroautophagy"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000111">
<property type="term" value="P:positive regulation of macrophage apoptotic process"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045348">
<property type="term" value="P:positive regulation of MHC class II biosynthetic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0014068">
<property type="term" value="P:positive regulation of phosphatidylinositol 3-kinase signaling"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001934">
<property type="term" value="P:positive regulation of protein phosphorylation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051152">
<property type="term" value="P:positive regulation of smooth muscle cell differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043161">
<property type="term" value="P:proteasome-mediated ubiquitin-dependent protein catabolic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006476">
<property type="term" value="P:protein deacetylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0106230">
<property type="term" value="P:protein depropionylation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031648">
<property type="term" value="P:protein destabilization"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016567">
<property type="term" value="P:protein ubiquitination"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000720">
<property type="term" value="P:pyrimidine dimer repair by nucleotide-excision repair"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000183">
<property type="term" value="P:rDNA heterochromatin assembly"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042981">
<property type="term" value="P:regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070857">
<property type="term" value="P:regulation of bile acid biosynthetic process"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0090335">
<property type="term" value="P:regulation of brown fat cell differentiation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042127">
<property type="term" value="P:regulation of cell population proliferation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1900034">
<property type="term" value="P:regulation of cellular response to heat"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0032071">
<property type="term" value="P:regulation of endodeoxyribonuclease activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010906">
<property type="term" value="P:regulation of glucose metabolic process"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010883">
<property type="term" value="P:regulation of lipid storage"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007346">
<property type="term" value="P:regulation of mitotic cell cycle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035358">
<property type="term" value="P:regulation of peroxisome proliferator activated receptor signaling pathway"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0071900">
<property type="term" value="P:regulation of protein serine/threonine kinase activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="AgBase"/>
</dbReference>
<dbReference type="GO" id="GO:0034391">
<property type="term" value="P:regulation of smooth muscle cell apoptotic process"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042542">
<property type="term" value="P:response to hydrogen peroxide"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032868">
<property type="term" value="P:response to insulin"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0044321">
<property type="term" value="P:response to leptin"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006979">
<property type="term" value="P:response to oxidative stress"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000012">
<property type="term" value="P:single strand break repair"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007283">
<property type="term" value="P:spermatogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0090400">
<property type="term" value="P:stress-induced premature senescence"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CACAO"/>
</dbReference>
<dbReference type="GO" id="GO:0007179">
<property type="term" value="P:transforming growth factor beta receptor signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0006642">
<property type="term" value="P:triglyceride mobilization"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0070914">
<property type="term" value="P:UV-damage excision repair"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CACAO"/>
</dbReference>
<dbReference type="GO" id="GO:0016032">
<property type="term" value="P:viral process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0050872">
<property type="term" value="P:white fat cell differentiation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="Gene3D" id="3.30.1600.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR029035">
<property type="entry name" value="DHS-like_NAD/FAD-binding_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR003000">
<property type="entry name" value="Sirtuin"/>
</dbReference>
<dbReference type="InterPro" id="IPR026591">
<property type="entry name" value="Sirtuin_cat_small_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR026590">
<property type="entry name" value="Ssirtuin_cat_dom"/>
</dbReference>
<dbReference type="Pfam" id="PF02146">
<property type="entry name" value="SIR2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF52467">
<property type="entry name" value="SSF52467"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50305">
<property type="entry name" value="SIRTUIN"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0053">Apoptosis</keyword>
<keyword id="KW-0090">Biological rhythms</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0217">Developmental protein</keyword>
<keyword id="KW-0221">Differentiation</keyword>
<keyword id="KW-0945">Host-virus interaction</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0488">Methylation</keyword>
<keyword id="KW-0496">Mitochondrion</keyword>
<keyword id="KW-0517">Myogenesis</keyword>
<keyword id="KW-0520">NAD</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0702">S-nitrosylation</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0862">Zinc</keyword>
<feature type="initiator methionine" description="Removed" evidence="8 10 11 12 13">
<location>
<position position="1"/>
</location>
</feature>
<feature type="chain" description="NAD-dependent protein deacetylase sirtuin-1" id="PRO_0000110256">
<location>
<begin position="2"/>
<end position="747"/>
</location>
</feature>
<feature type="chain" description="SirtT1 75 kDa fragment" id="PRO_0000415289">
<location>
<begin position="2"/>
<end position="533"/>
</location>
</feature>
<feature type="domain" description="Deacetylase sirtuin-type" evidence="19">
<location>
<begin position="244"/>
<end position="498"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="NAD" evidence="17">
<location>
<begin position="261"/>
<end position="280"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="NAD" evidence="17">
<location>
<begin position="345"/>
<end position="348"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="NAD" evidence="17">
<location>
<begin position="440"/>
<end position="442"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="NAD" evidence="17">
<location>
<begin position="465"/>
<end position="467"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with H1-4" evidence="31">
<location>
<begin position="2"/>
<end position="268"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with CLOCK" evidence="18">
<location>
<begin position="2"/>
<end position="139"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with CCAR2">
<location>
<begin position="143"/>
<end position="541"/>
</location>
</feature>
<feature type="region of interest" description="Required for interaction with the sumoylated form of CCAR2" evidence="101">
<location>
<begin position="256"/>
<end position="259"/>
</location>
</feature>
<feature type="region of interest" description="Phosphorylated at one of three serine residues">
<location>
<begin position="538"/>
<end position="540"/>
</location>
</feature>
<feature type="short sequence motif" description="Nuclear localization signal" evidence="16">
<location>
<begin position="32"/>
<end position="39"/>
</location>
</feature>
<feature type="short sequence motif" description="Nuclear export signal" evidence="16">
<location>
<begin position="138"/>
<end position="145"/>
</location>
</feature>
<feature type="short sequence motif" description="Nuclear localization signal" evidence="16">
<location>
<begin position="223"/>
<end position="230"/>
</location>
</feature>
<feature type="short sequence motif" description="Nuclear export signal" evidence="16">
<location>
<begin position="425"/>
<end position="431"/>
</location>
</feature>
<feature type="compositionally biased region" description="Ala-rich">
<location>
<begin position="54"/>
<end position="98"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Asp">
<location>
<begin position="122"/>
<end position="127"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Glu">
<location>
<begin position="128"/>
<end position="134"/>
</location>
</feature>
<feature type="active site" description="Proton acceptor" evidence="21 22 24 40 48 50 54 65 101">
<location>
<position position="363"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc" evidence="19">
<location>
<position position="371"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc" evidence="19">
<location>
<position position="374"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc" evidence="19">
<location>
<position position="395"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc" evidence="19">
<location>
<position position="398"/>
</location>
</feature>
<feature type="binding site" description="NAD; via amide nitrogen" evidence="16">
<location>
<position position="482"/>
</location>
</feature>
<feature type="modified residue" description="N-acetylalanine" evidence="8 10 11 12 13">
<location>
<position position="2"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10 11 14 15 58">
<location>
<position position="14"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="58">
<location>
<position position="26"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by MAPK8" evidence="14 15 57 58 66">
<location>
<position position="27"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by MAPK8" evidence="6 10 11 14 57 58 66 82">
<location>
<position position="47"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="109">
<location>
<position position="159"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="109">
<location>
<position position="162"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="58">
<location>
<position position="172"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="58">
<location>
<position position="173"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="18">
<location>
<position position="238"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="18">
<location>
<position position="377"/>
</location>
</feature>
<feature type="modified residue" description="S-nitrosocysteine" evidence="18">
<location>
<position position="395"/>
</location>
</feature>
<feature type="modified residue" description="S-nitrosocysteine" evidence="18">
<location>
<position position="398"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="18">
<location>
<position position="430"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="18">
<location>
<position position="513"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by DYRK1A, DYRK3 and MAPK8" evidence="9 58 66">
<location>
<position position="530"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="9">
<location>
<position position="535"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="109">
<location>
<position position="544"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="109">
<location>
<position position="545"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="18">
<location>
<position position="610"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by CaMK2" evidence="18">
<location>
<position position="659"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by CaMK2" evidence="111">
<location>
<position position="661"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="7 9 11 14 58">
<location>
<position position="719"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="58">
<location>
<position position="747"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_042189" evidence="107">
<location>
<begin position="454"/>
<end position="639"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs35671182." id="VAR_025148" evidence="106">
<original>D</original>
<variation>E</variation>
<location>
<position position="3"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1063111." id="VAR_051976">
<original>V</original>
<variation>D</variation>
<location>
<position position="484"/>
</location>
</feature>
<feature type="mutagenesis site" description="Greatly diminishes phosphorylation by MAPK8; when associated with A-47 and A-530." evidence="66">
<original>S</original>
<variation>A</variation>
<location>
<position position="27"/>
</location>
</feature>
<feature type="mutagenesis site" description="Blocks residue phosphorylation, restores deacetylation activity and inhibits DNA damage-induced apoptosis." evidence="66 82">
<original>S</original>
<variation>A</variation>
<location>
<position position="47"/>
</location>
</feature>
<feature type="mutagenesis site" description="Greatly diminishes phosphorylation by MAPK8; when associated with A-27 and A-530." evidence="66 82">
<original>S</original>
<variation>A</variation>
<location>
<position position="47"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs in vitro methylation by SETD7; when associated with R-235, R-236 and R-238." evidence="81">
<original>K</original>
<variation>R</variation>
<location>
<position position="233"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs in vitro methylation by SETD7; when associated with R-233, R-236 and R-238." evidence="81">
<original>K</original>
<variation>R</variation>
<location>
<position position="235"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs in vitro methylation by SETD7; when associated with R-233, R-235 and R-238." evidence="81">
<original>K</original>
<variation>R</variation>
<location>
<position position="236"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs in vitro methylation by SETD7; when associated with R-233, R-235a and R-236." evidence="81">
<original>K</original>
<variation>R</variation>
<location>
<position position="238"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of interaction with the sumoylated form of CCAR2. No effect on its deacetylation activity." evidence="101">
<original>II</original>
<variation>KK</variation>
<location>
<begin position="256"/>
<end position="257"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of function. Reduces the interaction with CCAR2 and APEX1. Increases acetylation of APEX1." evidence="21 22 24 40 48 50 54 65 101">
<original>H</original>
<variation>Y</variation>
<location>
<position position="363"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes phosphorylation at Ser-47, restores deacetylation activity and inhibits DNA damage-induced apoptosis." evidence="82">
<original>F</original>
<variation>A</variation>
<location>
<position position="474"/>
</location>
</feature>
<feature type="mutagenesis site" description="Greatly diminishes phosphorylation by MAPK8; when associated with A-27 and A-47." evidence="58 66">
<original>T</original>
<variation>A</variation>
<location>
<position position="530"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces in vitro phosphorylation by CDK1. Impairs cell proliferation and cell cycle progression; when associated with A-540." evidence="58 66">
<original>T</original>
<variation>A</variation>
<location>
<position position="530"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces in vitro phosphorylation by CDK1. Impairs cell proliferation and cell cycle progression; when associated with A-530." evidence="58">
<original>S</original>
<variation>A</variation>
<location>
<position position="540"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces in vitro phosphorylation by CaMK2; when associated with S-661. Greatly reduces in vivo phosphorylation; when associated with A-661." evidence="61">
<original>S</original>
<variation>A</variation>
<location>
<position position="659"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces in vitro phosphorylation by CaMK2; when associated with S-659. Greatly reduces in vivo phosphorylation; when associated with A-659." evidence="61">
<original>S</original>
<variation>A</variation>
<location>
<position position="661"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on phosphorylation (in vitro and in vivo)." evidence="61">
<original>S</original>
<variation>A</variation>
<location>
<position position="684"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; AAH12499." ref="5" evidence="107">
<original>DIFN</original>
<variation>ALFS</variation>
<location>
<begin position="386"/>
<end position="389"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="184"/>
<end position="194"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="198"/>
<end position="205"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="217"/>
<end position="228"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="243"/>
<end position="252"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="254"/>
<end position="260"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="262"/>
<end position="268"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="273"/>
<end position="275"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="276"/>
<end position="278"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="279"/>
<end position="286"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="290"/>
<end position="292"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="293"/>
<end position="297"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="299"/>
<end position="304"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="307"/>
<end position="312"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="313"/>
<end position="316"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="318"/>
<end position="320"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="325"/>
<end position="335"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="339"/>
<end position="344"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="350"/>
<end position="354"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="358"/>
<end position="361"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="364"/>
<end position="371"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="372"/>
<end position="374"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="377"/>
<end position="379"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="380"/>
<end position="382"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="384"/>
<end position="388"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="396"/>
<end position="398"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="406"/>
<end position="411"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="420"/>
<end position="429"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="430"/>
<end position="432"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="435"/>
<end position="440"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="448"/>
<end position="450"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="451"/>
<end position="454"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="461"/>
<end position="467"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="475"/>
<end position="480"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="482"/>
<end position="493"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="495"/>
<end position="500"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="506"/>
<end position="510"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="643"/>
<end position="645"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="646"/>
<end position="648"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="649"/>
<end position="651"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="656"/>
<end position="658"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4I5I"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4IG9"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4KXQ"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4ZZI"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5BTR"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="16964243"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19413330"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="21406692"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="22223895"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="22814378"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000250"/>
<evidence key="17" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q8IXJ6"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q923E4"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00236"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10381378"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11672523"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12006491"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12297502"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12535671"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12939617"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14976264"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14980222"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15126506"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15152190"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15205477"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15469825"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15684044"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15692560"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15719057"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16079181"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16166628"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16892051"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16998810"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17283066"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17290224"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17334224"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17505061"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17612497"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17620057"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17680780"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17936707"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17964266"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18004385"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18203716"/>
</source>
</evidence>
<evidence key="50" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18235501"/>
</source>
</evidence>
<evidence key="51" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18235502"/>
</source>
</evidence>
<evidence key="52" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18296641"/>
</source>
</evidence>
<evidence key="53" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18329615"/>
</source>
</evidence>
<evidence key="54" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18485871"/>
</source>
</evidence>
<evidence key="55" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18662546"/>
</source>
</evidence>
<evidence key="56" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18687677"/>
</source>
</evidence>
<evidence key="57" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18838864"/>
</source>
</evidence>
<evidence key="58" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19107194"/>
</source>
</evidence>
<evidence key="59" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19188449"/>
</source>
</evidence>
<evidence key="60" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19220062"/>
</source>
</evidence>
<evidence key="61" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19236849"/>
</source>
</evidence>
<evidence key="62" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19356714"/>
</source>
</evidence>
<evidence key="63" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19364925"/>
</source>
</evidence>
<evidence key="64" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19690166"/>
</source>
</evidence>
<evidence key="65" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19934257"/>
</source>
</evidence>
<evidence key="66" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20027304"/>
</source>
</evidence>
<evidence key="67" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20042607"/>
</source>
</evidence>
<evidence key="68" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20097625"/>
</source>
</evidence>
<evidence key="69" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20100829"/>
</source>
</evidence>
<evidence key="70" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20167603"/>
</source>
</evidence>
<evidence key="71" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20169165"/>
</source>
</evidence>
<evidence key="72" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20203304"/>
</source>
</evidence>
<evidence key="73" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20375098"/>
</source>
</evidence>
<evidence key="74" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20620956"/>
</source>
</evidence>
<evidence key="75" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20670893"/>
</source>
</evidence>
<evidence key="76" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20817729"/>
</source>
</evidence>
<evidence key="77" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20955178"/>
</source>
</evidence>
<evidence key="78" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20975832"/>
</source>
</evidence>
<evidence key="79" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21149730"/>
</source>
</evidence>
<evidence key="80" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21212262"/>
</source>
</evidence>
<evidence key="81" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21245319"/>
</source>
</evidence>
<evidence key="82" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21471201"/>
</source>
</evidence>
<evidence key="83" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21504832"/>
</source>
</evidence>
<evidence key="84" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21555002"/>
</source>
</evidence>
<evidence key="85" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21698133"/>
</source>
</evidence>
<evidence key="86" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21701047"/>
</source>
</evidence>
<evidence key="87" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21775285"/>
</source>
</evidence>
<evidence key="88" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21807113"/>
</source>
</evidence>
<evidence key="89" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21841822"/>
</source>
</evidence>
<evidence key="90" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21890893"/>
</source>
</evidence>
<evidence key="91" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21909281"/>
</source>
</evidence>
<evidence key="92" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21933665"/>
</source>
</evidence>
<evidence key="93" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21947282"/>
</source>
</evidence>
<evidence key="94" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21987377"/>
</source>
</evidence>
<evidence key="95" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22274616"/>
</source>
</evidence>
<evidence key="96" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23352644"/>
</source>
</evidence>
<evidence key="97" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24043310"/>
</source>
</evidence>
<evidence key="98" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24415752"/>
</source>
</evidence>
<evidence key="99" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24824780"/>
</source>
</evidence>
<evidence key="100" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25361978"/>
</source>
</evidence>
<evidence key="101" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25406032"/>
</source>
</evidence>
<evidence key="102" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25661920"/>
</source>
</evidence>
<evidence key="103" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="29656858"/>
</source>
</evidence>
<evidence key="104" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="30193097"/>
</source>
</evidence>
<evidence key="105" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="31722219"/>
</source>
</evidence>
<evidence key="106" type="ECO:0000269">
<source ref="3"/>
</evidence>
<evidence key="107" type="ECO:0000305"/>
<evidence key="108" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="15469825"/>
</source>
</evidence>
<evidence key="109" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="19107194"/>
</source>
</evidence>
<evidence key="110" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="19220062"/>
</source>
</evidence>
<evidence key="111" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="19236849"/>
</source>
</evidence>
<evidence key="112" type="ECO:0000312">
<source>
<dbReference type="HGNC" id="HGNC:14929"/>
</source>
</evidence>
<sequence length="747" mass="81681" checksum="2D3BEA6D73DA229F" modified="2003-10-31" version="2">MADEAALALQPGGSPSAAGADREAASSPAGEPLRKRPRRDGPGLERSPGEPGGAAPEREVPAAARGCPGAAAAALWREAEAEAAAAGGEQEAQATAAAGEGDNGPGLQGPSREPPLADNLYDEDDDDEGEEEEEAAAAAIGYRDNLLFGDEIITNGFHSCESDEEDRASHASSSDWTPRPRIGPYTFVQQHLMIGTDPRTILKDLLPETIPPPELDDMTLWQIVINILSEPPKRKKRKDINTIEDAVKLLQECKKIIVLTGAGVSVSCGIPDFRSRDGIYARLAVDFPDLPDPQAMFDIEYFRKDPRPFFKFAKEIYPGQFQPSLCHKFIALSDKEGKLLRNYTQNIDTLEQVAGIQRIIQCHGSFATASCLICKYKVDCEAVRGDIFNQVVPRCPRCPADEPLAIMKPEIVFFGENLPEQFHRAMKYDKDEVDLLIVIGSSLKVRPVALIPSSIPHEVPQILINREPLPHLHFDVELLGDCDVIINELCHRLGGEYAKLCCNPVKLSEITEKPPRTQKELAYLSELPPTPLHVSEDSSSPERTSPPDSSVIVTLLDQAAKSNDDLDVSESKGCMEEKPQEVQTSRNVESIAEQMENPDLKNVGSSTGEKNERTSVAGTVRKCWPNRVAKEQISRRLDGNQYLFLPPNRYIFHGAEVYSDSEDDVLSSSSCGSNSDSGTCQSPSLEEPMEDESEIEEFYNGLEDEPDVPERAGGAGFGTDGDDQEAINEAISVKQEVTDMNYPSNKS</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

